data_1i8x_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1i8x _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 13.4 m . . . . . 0 N--CA 1.485 1.31 0 CA-C-O 120.765 0.317 . . . . 0.0 111.155 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.752 ' HB ' ' HB2' ' A' ' 10' ' ' CYS . 3.8 mp -117.3 113.49 42.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.977 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 25.0 m-70 -102.62 -45.37 5.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.806 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.406 ' HB3' ' H ' ' A' ' 5' ' ' ASP . 0.0 OUTLIER 58.81 -90.13 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.218 179.89 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.406 ' H ' ' HB3' ' A' ' 4' ' ' CYS . 2.4 t0 -79.84 4.09 17.63 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.946 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 56.77 27.48 12.84 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.96 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -129.49 -14.14 4.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.104 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.25 123.96 14.15 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.192 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 7.5 mt -86.58 154.99 3.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.992 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.752 ' HB2' ' HB ' ' A' ' 2' ' ' ILE . 22.9 m -144.68 153.14 54.26 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.065 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -63.56 141.39 79.95 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.424 2.083 . . . . 0.0 112.022 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -59.52 104.13 0.25 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.684 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 134.1 0.49 3.82 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.466 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.418 ' O ' HG12 ' A' ' 2' ' ' ILE . 43.6 p -116.97 153.96 31.71 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.822 0.344 . . . . 0.0 111.179 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.415 ' HG1' ' N ' ' A' ' 16' ' ' CYS . 10.1 t -105.31 156.06 18.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.142 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.415 ' N ' ' HG1' ' A' ' 15' ' ' THR . 0.0 OUTLIER -82.18 113.14 19.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.663 179.822 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.1 m -124.65 132.7 53.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.9 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.2 mt -89.02 136.47 33.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.022 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -83.15 160.42 60.16 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.513 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -58.07 -11.95 11.45 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.464 2.109 . . . . 0.0 112.529 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.6 24.01 12.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.779 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 62.8 52.64 46.86 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 121.045 -0.598 . . . . 0.0 112.647 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.7 t -124.02 114.76 42.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.726 0.298 . . . . 0.0 110.766 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -72.78 121.09 19.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.064 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 54.9 p90 -137.65 153.68 49.82 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.888 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -90.03 125.64 35.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.093 -179.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.2 t -114.98 118.98 39.83 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.783 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.14 139.73 56.73 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.398 2.065 . . . . 0.0 112.465 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 42.9 p90 . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.889 179.921 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 1.6 m . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.753 0.311 . . . . 0.0 111.08 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.695 ' HB ' ' HB2' ' A' ' 10' ' ' CYS . 7.5 mm -109.07 121.69 62.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.507 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 10.3 m170 -121.26 119.92 33.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.273 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.2 m -120.29 -18.21 8.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.654 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -146.72 7.85 0.97 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.641 0.258 . . . . 0.0 111.248 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 55.91 21.46 4.91 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.214 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -124.03 -51.76 1.78 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.961 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.2 m -105.45 92.44 4.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.965 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 22.4 mt -67.92 137.06 25.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.22 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.695 ' HB2' ' HB ' ' A' ' 2' ' ' ILE . 9.5 m -117.04 159.52 40.74 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.775 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -79.05 145.7 19.68 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.34 2.027 . . . . 0.0 111.992 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.459 ' HA ' HD12 ' A' ' 2' ' ' ILE . 1.9 t70 -61.53 109.59 1.22 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.872 0.368 . . . . 0.0 110.844 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 130.12 14.64 1.99 Allowed Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.635 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.422 HG23 ' HA ' ' A' ' 28' ' ' PRO . 1.1 p -139.11 154.07 48.09 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.749 0.309 . . . . 0.0 111.156 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.443 HG23 ' O ' ' A' ' 27' ' ' SER . 4.1 t -104.27 153.06 21.46 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.177 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.2 m -73.61 114.01 11.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.055 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.423 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 0.4 OUTLIER -120.87 129.99 53.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.596 179.773 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.4 mt -94.46 140.01 30.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.888 0.375 . . . . 0.0 111.181 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.526 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 0.1 OUTLIER -86.77 162.03 45.82 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.532 179.805 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.31 -8.06 6.12 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.458 2.105 . . . . 0.0 112.714 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -118.05 23.68 11.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.824 0.345 . . . . 0.0 111.094 -179.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.28 46.77 85.66 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.673 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.526 ' HB ' ' HB2' ' A' ' 19' ' ' SER . 60.6 t -113.82 117.73 56.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.805 0.336 . . . . 0.0 110.74 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 87.5 m95 -77.78 117.06 18.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.35 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.423 ' CE2' ' HB3' ' A' ' 17' ' ' SER . 53.8 p90 -137.98 147.22 44.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.501 179.241 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -85.31 122.81 30.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.096 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.443 ' O ' HG23 ' A' ' 15' ' ' THR . 24.9 t -116.03 125.5 28.55 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.033 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.422 ' HA ' HG23 ' A' ' 14' ' ' THR . 59.6 Cg_endo -71.93 152.0 57.13 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.482 2.121 . . . . 0.0 112.324 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.856 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 1.8 m . . . . . 0 N--CA 1.486 1.329 0 CA-C-O 120.751 0.31 . . . . 0.0 111.119 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.555 HD13 ' HA ' ' A' ' 12' ' ' ASP . 6.1 mm -121.09 135.65 60.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.1 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 70.8 m-70 -138.42 87.48 2.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.794 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 12.0 m -79.15 -53.37 7.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.985 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -114.68 11.35 16.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.116 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 56.01 23.57 6.88 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.335 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -115.79 -56.6 2.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.077 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 87.4 m -105.68 100.32 9.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.023 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 6.3 mt -68.83 128.63 32.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.728 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.2 m -119.59 150.36 49.9 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.207 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -59.18 147.8 88.89 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.631 2.221 . . . . 0.0 112.358 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.555 ' HA ' HD13 ' A' ' 2' ' ' ILE . 7.2 p-10 -58.66 -25.35 62.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.406 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -88.49 21.28 26.37 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.694 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.1 p -146.14 177.6 8.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.843 0.354 . . . . 0.0 111.194 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.42 ' O ' ' HA ' ' A' ' 26' ' ' CYS . 6.7 t -132.57 159.96 37.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.02 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.506 ' SG ' HG23 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -84.16 105.33 14.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.1 -179.864 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.654 ' HG ' ' HB2' ' A' ' 27' ' ' SER . 0.7 OUTLIER -118.35 139.65 51.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.491 179.655 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.4 mt -92.85 143.96 25.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.03 0.443 . . . . 0.0 111.328 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.7 164.04 18.34 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.403 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_exo -58.36 -4.8 1.88 Allowed 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.491 2.127 . . . . 0.0 112.812 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.403 ' HD2' HG23 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -117.61 21.53 12.92 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.799 0.333 . . . . 0.0 110.91 -179.741 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 62.91 44.36 97.54 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.534 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.403 HG23 ' HD2' ' A' ' 21' ' ' TYR . 54.2 t -113.0 132.55 61.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.755 0.312 . . . . 0.0 110.866 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 82.7 m95 -91.06 104.84 17.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.219 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 55.1 p90 -118.3 152.74 35.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.557 179.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.42 ' HA ' ' O ' ' A' ' 15' ' ' THR . 1.8 m -91.86 117.06 29.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.026 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.654 ' HB2' ' HG ' ' A' ' 17' ' ' SER . 0.1 OUTLIER -105.47 132.58 20.76 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.726 179.911 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -74.14 140.42 28.02 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.339 2.026 . . . . 0.0 112.515 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 55.4 p90 . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.905 179.771 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 26.9 m . . . . . 0 N--CA 1.485 1.315 0 CA-C-O 120.789 0.328 . . . . 0.0 111.062 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.534 ' HB ' ' HB2' ' A' ' 10' ' ' CYS . 12.6 mm -121.48 119.75 59.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.245 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . 0.413 ' HD1' ' HA ' ' A' ' 6' ' ' ALA . 14.1 m-70 -126.62 85.17 2.35 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.72 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.2 m -72.26 -58.84 3.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.997 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -115.82 32.55 6.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.063 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.413 ' HA ' ' HD1' ' A' ' 3' ' ' HIS . . . 58.4 15.76 3.69 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.205 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -136.58 155.62 49.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.74 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 72.3 m 53.37 86.75 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.91 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 18.8 mt -71.21 130.6 35.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.092 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.534 ' HB2' ' HB ' ' A' ' 2' ' ' ILE . 13.0 m -112.29 155.08 44.13 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.809 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.474 ' HD2' ' HG1' ' A' ' 14' ' ' THR . 23.5 Cg_exo -64.41 139.97 67.59 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.516 2.144 . . . . 0.0 112.162 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -59.65 104.27 0.27 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.863 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 138.65 -12.12 3.44 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.473 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.474 ' HG1' ' HD2' ' A' ' 11' ' ' PRO . 47.5 p -108.04 161.52 14.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.763 0.316 . . . . 0.0 111.121 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.4 t -111.28 144.87 39.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.089 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -76.33 114.25 14.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.874 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.7 t -122.1 139.96 53.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.849 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.5 mt -95.06 125.73 39.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.899 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.25 159.91 81.2 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.774 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -54.04 -12.04 3.19 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.792 2.328 . . . . 0.0 112.851 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -105.19 -27.2 11.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.969 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 117.27 52.95 0.32 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.516 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 23.3 t -124.7 129.57 73.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.766 0.317 . . . . 0.0 111.042 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 92.7 m95 -82.78 99.24 9.56 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.04 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -116.36 151.7 35.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.727 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.426 ' HB3' ' OG1' ' A' ' 14' ' ' THR . 0.2 OUTLIER -89.18 127.36 35.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.247 -179.638 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -118.49 114.21 36.31 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.717 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -66.55 130.64 24.08 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.411 2.074 . . . . 0.0 112.194 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 12.7 p90 . . . . . 0 C--N 1.328 -0.365 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.849 179.799 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . 0.4 ' H3 ' HG22 ' A' ' 1' ' ' VAL . 17.1 m . . . . . 0 N--CA 1.485 1.308 0 CA-C-O 120.775 0.322 . . . . 0.0 111.175 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.445 HG22 ' SG ' ' A' ' 4' ' ' CYS . 3.3 mm -101.3 145.22 11.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.114 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 26.1 m-70 -133.9 -33.6 1.04 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.915 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.445 ' SG ' HG22 ' A' ' 2' ' ' ILE . 0.4 OUTLIER 55.51 -94.05 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.164 179.894 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.406 ' H ' ' HB2' ' A' ' 4' ' ' CYS . 0.9 OUTLIER -94.37 30.71 1.89 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.8 0.333 . . . . 0.0 110.666 179.881 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 60.91 14.49 5.28 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.068 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -134.85 153.31 52.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.818 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 90.2 m 55.64 87.29 0.05 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.864 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 8.0 mt -69.28 146.88 12.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.151 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 7.0 m -138.74 157.58 71.64 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.832 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.509 ' HD2' ' HG1' ' A' ' 14' ' ' THR . 25.6 Cg_exo -62.97 145.74 94.5 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.485 2.123 . . . . 0.0 112.085 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -60.76 -21.3 62.88 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.11 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -85.3 14.15 51.66 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.663 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.509 ' HG1' ' HD2' ' A' ' 11' ' ' PRO . 66.5 p -140.47 171.08 14.63 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.819 0.343 . . . . 0.0 111.187 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 8.9 t -126.71 162.53 25.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.109 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -74.98 120.76 20.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.969 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -128.19 131.98 48.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.586 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.1 mt -91.84 124.98 36.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.886 0.374 . . . . 0.0 111.135 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.459 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 0.1 OUTLIER -78.95 162.38 64.98 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.522 179.702 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -56.12 -11.41 5.77 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.487 2.124 . . . . 0.0 112.616 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -113.76 26.2 10.56 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.072 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 59.01 59.07 11.44 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.587 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.459 ' HB ' ' HB2' ' A' ' 19' ' ' SER . 41.0 t -126.64 120.52 56.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.824 0.345 . . . . 0.0 111.282 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 94.7 m95 -81.25 99.62 8.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.902 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 56.0 p90 -117.82 161.75 19.22 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.926 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.427 ' HB3' ' OG1' ' A' ' 14' ' ' THR . 0.0 OUTLIER -87.07 129.0 35.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.092 -179.768 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.11 117.15 17.97 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.895 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -61.74 144.77 97.44 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.494 2.129 . . . . 0.0 112.215 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.33 -0.24 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.869 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 2.9 m . . . . . 0 N--CA 1.485 1.316 0 CA-C-O 120.832 0.348 . . . . 0.0 111.148 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.554 HD11 ' HA ' ' A' ' 12' ' ' ASP . 3.0 mm -103.48 159.08 4.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.907 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 17.2 m-70 -137.25 -64.21 0.57 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.913 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.405 ' SG ' HG22 ' A' ' 2' ' ' ILE . 15.2 m 60.93 -86.4 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.194 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -74.73 -4.93 40.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.918 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 56.89 22.83 7.5 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.41 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -134.5 -21.46 1.76 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.024 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 42.8 m -130.46 94.26 3.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.972 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 10.8 mt -64.14 132.58 30.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.895 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.425 ' O ' HG12 ' A' ' 2' ' ' ILE . 6.4 m -120.27 153.33 55.72 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.164 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -56.59 142.88 90.2 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.603 2.202 . . . . 0.0 112.335 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.554 ' HA ' HD11 ' A' ' 2' ' ' ILE . 21.2 t0 -57.58 -24.28 55.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.379 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -92.69 21.47 38.74 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.884 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 82.2 p -141.28 173.77 11.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.902 0.382 . . . . 0.0 111.245 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.5 t -130.66 155.42 46.61 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.92 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -73.47 120.39 19.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.93 0.395 . . . . 0.0 110.986 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.6 t -132.18 135.92 46.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.52 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.1 mt -99.99 132.59 45.26 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.922 0.391 . . . . 0.0 111.073 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.557 ' HG ' ' H ' ' A' ' 21' ' ' TYR . 6.1 p -77.61 163.1 65.75 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.794 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.45 -6.43 4.17 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.592 2.195 . . . . 0.0 112.68 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.557 ' H ' ' HG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -117.1 20.57 13.7 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.813 0.339 . . . . 0.0 111.096 -179.735 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.52 47.58 76.69 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.903 -0.665 . . . . 0.0 113.009 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 51.8 t -117.6 117.15 54.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.765 0.317 . . . . 0.0 110.755 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -71.32 124.49 24.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.322 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 46.8 p90 -147.65 147.12 29.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.364 179.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -91.02 124.34 35.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.932 0.396 . . . . 0.0 111.275 -179.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 11.0 t -108.39 127.72 26.98 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.423 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -76.08 126.62 9.4 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.316 2.011 . . . . 0.0 112.445 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.816 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 6.1 m . . . . . 0 N--CA 1.485 1.315 0 CA-C-O 120.811 0.339 . . . . 0.0 111.024 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.649 ' HB ' ' HB2' ' A' ' 10' ' ' CYS . 4.7 mm -120.15 104.1 15.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.043 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 -95.49 74.96 3.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.919 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.414 ' HB2' ' HB ' ' A' ' 8' ' ' THR . 4.1 m -62.73 113.06 2.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.85 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 59.98 18.19 7.35 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.088 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 55.69 26.26 9.14 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.381 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -137.95 -2.07 1.93 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.253 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.414 ' HB ' ' HB2' ' A' ' 4' ' ' CYS . 21.7 m -143.28 108.3 4.95 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.285 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 5.8 mt -84.44 143.32 11.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.869 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.649 ' HB2' ' HB ' ' A' ' 2' ' ' ILE . 12.3 m -145.8 154.62 51.8 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.203 -179.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -57.86 143.5 95.63 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.536 2.158 . . . . 0.0 112.21 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -54.83 -31.77 59.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.282 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -85.15 23.33 8.21 Favored Glycine 0 CA--C 1.518 0.276 0 C-N-CA 120.892 -0.67 . . . . 0.0 113.253 -179.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 81.6 p -142.61 165.07 28.4 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.835 0.35 . . . . 0.0 111.259 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 8.2 t -124.69 164.1 20.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.018 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.52 ' SG ' HG21 ' A' ' 2' ' ' ILE . 3.6 m -80.47 118.76 22.36 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.259 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.548 ' HG ' ' HB3' ' A' ' 27' ' ' SER . 1.9 m -125.49 140.66 52.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.365 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.0 mt -94.28 131.92 39.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.011 0.434 . . . . 0.0 111.467 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.63 163.83 34.26 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.411 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -56.62 -8.36 2.84 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.549 2.166 . . . . 0.0 112.665 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -115.82 25.84 10.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.024 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 58.91 35.43 82.99 Favored Glycine 0 C--N 1.33 0.201 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.684 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 59.3 t -105.45 124.9 60.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.872 0.368 . . . . 0.0 111.039 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 80.9 m95 -82.29 112.33 19.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.205 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 49.3 p90 -125.18 154.0 42.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.682 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -86.44 129.12 34.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.923 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.548 ' HB3' ' HG ' ' A' ' 17' ' ' SER . 28.1 t -130.96 125.33 21.17 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.03 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 27' ' ' SER . 16.3 Cg_exo -68.35 149.35 75.25 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.753 2.302 . . . . 0.0 112.204 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.93 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 3.9 m . . . . . 0 N--CA 1.485 1.314 0 CA-C-O 120.835 0.35 . . . . 0.0 111.172 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.785 ' HB ' ' HB2' ' A' ' 10' ' ' CYS . 5.2 mm -92.27 129.27 43.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.245 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 16.8 m-70 -121.61 -44.13 2.35 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.088 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.586 ' SG ' HG22 ' A' ' 2' ' ' ILE . 0.7 OUTLIER 58.8 -90.84 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.5 179.875 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -79.61 2.51 22.15 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.088 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 58.23 16.76 4.17 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.364 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -100.98 -36.24 9.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.85 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 14.8 t -125.33 159.67 31.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.915 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 44.0 mt -111.1 142.59 23.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.93 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.785 ' HB2' ' HB ' ' A' ' 2' ' ' ILE . 56.4 m -134.43 157.22 77.89 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.905 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -76.38 141.33 22.69 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.308 2.006 . . . . 0.0 112.167 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -55.43 99.96 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.116 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 140.59 -4.79 2.53 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.471 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.419 ' O ' HG13 ' A' ' 2' ' ' ILE . 12.2 p -113.12 151.31 30.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.726 0.298 . . . . 0.0 110.867 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.2 t -105.21 152.73 22.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.281 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -76.21 112.49 12.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.646 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -120.69 141.74 50.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.078 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.525 HD21 ' HA2' ' A' ' 22' ' ' GLY . 6.6 mt -97.65 125.79 42.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.799 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.439 ' HB3' ' HB ' ' A' ' 23' ' ' VAL . 0.3 OUTLIER -77.6 164.06 60.11 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.785 -179.89 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.448 ' HG2' ' CZ ' ' A' ' 21' ' ' TYR . 9.5 Cg_endo -54.6 -12.08 3.97 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 122.742 2.295 . . . . 0.0 112.691 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.448 ' CZ ' ' HG2' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -117.57 30.11 7.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.035 -179.518 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.525 ' HA2' HD21 ' A' ' 18' ' ' LEU . . . 56.8 48.81 75.25 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.568 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.439 ' HB ' ' HB3' ' A' ' 19' ' ' SER . 16.2 t -113.46 117.15 54.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.795 0.331 . . . . 0.0 111.066 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -76.07 105.06 6.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.209 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -123.47 156.48 35.49 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.834 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 1.6 m -87.95 108.28 19.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.224 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -94.55 117.38 66.99 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.632 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.35 127.33 13.22 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.467 2.111 . . . . 0.0 112.484 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 50.0 p90 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.006 179.952 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . 0.491 HG21 HG22 ' A' ' 9' ' ' ILE . 16.0 m . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.822 0.344 . . . . 0.0 111.145 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.424 HG22 ' SG ' ' A' ' 16' ' ' CYS . 13.3 mm -84.35 116.74 28.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.104 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . 0.416 ' HD1' ' HA ' ' A' ' 6' ' ' ALA . 1.2 m-70 -94.17 -48.76 6.06 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.025 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 63.54 -84.35 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.207 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 20.0 p-10 -86.33 9.62 17.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.151 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.416 ' HA ' ' HD1' ' A' ' 3' ' ' HIS . . . 55.09 29.38 12.39 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.237 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -137.27 -31.46 0.81 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.244 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.4 m -112.26 118.55 35.59 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.271 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.491 HG22 HG21 ' A' ' 1' ' ' VAL . 2.6 mp -88.69 142.16 13.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.845 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.415 ' HB3' ' OG1' ' A' ' 14' ' ' THR . 20.5 m -105.37 152.63 39.93 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.395 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.48 ' O ' ' HB2' ' A' ' 12' ' ' ASP . 10.8 Cg_exo -73.38 18.69 0.39 Allowed 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 123.09 2.526 . . . . 0.0 112.958 -179.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.48 ' HB2' ' O ' ' A' ' 11' ' ' PRO . 21.5 m-20 69.65 138.14 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.034 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 78.18 22.41 68.25 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.194 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.485 ' OG1' ' HB3' ' A' ' 26' ' ' CYS . 70.5 p -129.26 175.02 9.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.83 0.348 . . . . 0.0 111.185 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.9 t -128.79 152.95 47.9 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.01 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.424 ' SG ' HG22 ' A' ' 2' ' ' ILE . 1.7 m -72.7 112.5 8.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.164 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -127.75 136.93 52.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.657 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.2 mt -91.57 150.22 21.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.076 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.425 ' HG ' ' H ' ' A' ' 21' ' ' TYR . 1.1 p -94.05 161.35 30.02 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.791 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -55.73 -13.91 9.38 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.553 2.169 . . . . 0.0 112.511 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.425 ' H ' ' HG ' ' A' ' 19' ' ' SER . 0.1 OUTLIER -102.93 -22.03 13.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.848 -179.723 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 113.29 28.64 3.24 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.633 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.432 HG13 ' N ' ' A' ' 24' ' ' TRP . 48.5 t -96.96 140.02 18.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.803 0.335 . . . . 0.0 110.947 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.432 ' N ' HG13 ' A' ' 23' ' ' VAL . 67.3 m95 -93.08 103.42 15.72 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.261 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 55.3 p90 -119.66 168.32 11.16 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.318 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.485 ' HB3' ' OG1' ' A' ' 14' ' ' THR . 15.6 m -107.85 138.13 44.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.927 0.394 . . . . 0.0 111.441 -179.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.8 m -125.73 118.72 24.29 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.697 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.459 ' HA ' ' HA ' ' A' ' 14' ' ' THR . 19.9 Cg_exo -65.49 135.3 41.88 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.577 2.184 . . . . 0.0 112.321 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 28.1 p90 . . . . . 0 C--N 1.331 -0.229 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.049 179.921 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 13.6 m . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.796 0.331 . . . . 0.0 111.105 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 12.2 mm -78.33 137.2 22.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.239 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . 0.404 ' CE1' HG12 ' A' ' 9' ' ' ILE . 9.8 m-70 -120.83 -47.46 2.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.847 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 60.94 -87.1 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.38 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.66 -0.0 19.17 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.004 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 59.71 23.14 11.97 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.005 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -120.55 -45.12 2.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.932 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.3 t -104.31 152.47 22.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.933 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.404 HG12 ' CE1' ' A' ' 3' ' ' HIS . 17.9 mt -111.52 136.4 47.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.808 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 16.9 m -137.24 162.13 57.1 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.006 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.405 ' HG2' ' OG1' ' A' ' 14' ' ' THR . 36.8 Cg_endo -66.38 147.18 82.5 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.128 1.886 . . . . 0.0 111.934 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -64.07 -7.72 9.62 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.411 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -104.62 27.51 18.74 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.839 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.598 ' HG1' ' HB3' ' A' ' 26' ' ' CYS . 36.7 p -142.78 173.94 11.1 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.896 0.379 . . . . 0.0 111.258 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 10.0 t -126.33 160.11 31.3 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.025 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -74.04 111.53 9.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.715 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -116.68 136.19 53.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.03 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.8 mt -98.37 125.3 43.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.935 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.691 ' HB3' ' HB ' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -80.93 163.96 53.12 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.741 179.995 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.454 ' HG2' ' CE1' ' A' ' 21' ' ' TYR . 9.3 Cg_endo -54.12 -12.38 3.62 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.787 2.325 . . . . 0.0 112.692 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.454 ' CE1' ' HG2' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -116.78 32.47 6.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.927 -179.594 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 54.53 55.3 27.76 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.568 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.691 ' HB ' ' HB3' ' A' ' 19' ' ' SER . 40.7 t -116.02 123.84 71.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.824 0.345 . . . . 0.0 111.345 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 97.0 m95 -85.41 93.18 8.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.76 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -113.66 162.23 16.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.048 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.598 ' HB3' ' HG1' ' A' ' 14' ' ' THR . 0.0 OUTLIER -85.28 119.49 25.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.11 -179.68 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.419 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 4.8 t -111.19 116.19 51.59 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.904 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 27' ' ' SER . 7.4 Cg_exo -73.08 128.32 12.95 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.833 2.355 . . . . 0.0 112.275 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 1.9 p90 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.028 179.953 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 13.4 m . . . . . 0 N--CA 1.485 1.31 0 CA-C-O 120.765 0.317 . . . . 0.0 111.155 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.752 ' HB ' ' HB2' ' A' ' 10' ' ' CYS . 3.8 mp -117.3 113.49 42.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.977 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 25.0 m-70 -102.62 -45.37 5.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.806 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.406 ' HB3' ' H ' ' A' ' 5' ' ' ASP . 0.0 OUTLIER 58.81 -90.13 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.218 179.89 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.406 ' H ' ' HB3' ' A' ' 4' ' ' CYS . 2.4 t0 -79.84 4.09 17.63 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.946 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 56.77 27.48 12.84 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.96 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -129.49 -14.14 4.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.104 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.25 123.96 14.15 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.192 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 7.5 mt -86.58 154.99 3.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.992 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.752 ' HB2' ' HB ' ' A' ' 2' ' ' ILE . 22.9 m -144.68 153.14 54.26 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.065 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -63.56 141.39 79.95 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.424 2.083 . . . . 0.0 112.022 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -59.52 104.13 0.25 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.684 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 134.1 0.49 3.82 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.466 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.418 ' O ' HG12 ' A' ' 2' ' ' ILE . 43.6 p -116.97 153.96 31.71 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.822 0.344 . . . . 0.0 111.179 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.415 ' HG1' ' N ' ' A' ' 16' ' ' CYS . 10.1 t -105.31 156.06 18.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.142 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.415 ' N ' ' HG1' ' A' ' 15' ' ' THR . 0.0 OUTLIER -82.18 113.14 19.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.663 179.822 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.1 m -124.65 132.7 53.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.9 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.2 mt -89.02 136.47 33.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.022 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -83.15 160.42 60.16 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.513 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -58.07 -11.95 11.45 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.464 2.109 . . . . 0.0 112.529 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.6 24.01 12.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.779 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 62.8 52.64 46.86 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 121.045 -0.598 . . . . 0.0 112.647 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.7 t -124.02 114.76 42.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.726 0.298 . . . . 0.0 110.766 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -72.78 121.09 19.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.064 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 54.9 p90 -137.65 153.68 49.82 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.888 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -90.03 125.64 35.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.093 -179.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.2 t -114.98 118.98 39.83 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.783 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.14 139.73 56.73 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.398 2.065 . . . . 0.0 112.465 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 42.9 p90 -137.12 167.46 21.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.889 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 12.2 t . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.882 179.994 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 1.6 m . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.753 0.311 . . . . 0.0 111.08 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.695 ' HB ' ' HB2' ' A' ' 10' ' ' CYS . 7.5 mm -109.07 121.69 62.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.507 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 10.3 m170 -121.26 119.92 33.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.273 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.2 m -120.29 -18.21 8.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.654 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -146.72 7.85 0.97 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.641 0.258 . . . . 0.0 111.248 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 55.91 21.46 4.91 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.214 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -124.03 -51.76 1.78 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.961 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.2 m -105.45 92.44 4.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.965 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 22.4 mt -67.92 137.06 25.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.22 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.695 ' HB2' ' HB ' ' A' ' 2' ' ' ILE . 9.5 m -117.04 159.52 40.74 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.775 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -79.05 145.7 19.68 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.34 2.027 . . . . 0.0 111.992 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.459 ' HA ' HD12 ' A' ' 2' ' ' ILE . 1.9 t70 -61.53 109.59 1.22 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.872 0.368 . . . . 0.0 110.844 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 130.12 14.64 1.99 Allowed Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.635 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.422 HG23 ' HA ' ' A' ' 28' ' ' PRO . 1.1 p -139.11 154.07 48.09 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.749 0.309 . . . . 0.0 111.156 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.443 HG23 ' O ' ' A' ' 27' ' ' SER . 4.1 t -104.27 153.06 21.46 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.177 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.2 m -73.61 114.01 11.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.055 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.423 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 0.4 OUTLIER -120.87 129.99 53.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.596 179.773 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.4 mt -94.46 140.01 30.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.888 0.375 . . . . 0.0 111.181 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.526 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 0.1 OUTLIER -86.77 162.03 45.82 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.532 179.805 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.31 -8.06 6.12 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.458 2.105 . . . . 0.0 112.714 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -118.05 23.68 11.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.824 0.345 . . . . 0.0 111.094 -179.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.28 46.77 85.66 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.673 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.526 ' HB ' ' HB2' ' A' ' 19' ' ' SER . 60.6 t -113.82 117.73 56.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.805 0.336 . . . . 0.0 110.74 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 87.5 m95 -77.78 117.06 18.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.35 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.423 ' CE2' ' HB3' ' A' ' 17' ' ' SER . 53.8 p90 -137.98 147.22 44.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.501 179.241 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -85.31 122.81 30.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.096 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.443 ' O ' HG23 ' A' ' 15' ' ' THR . 24.9 t -116.03 125.5 28.55 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.033 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.422 ' HA ' HG23 ' A' ' 14' ' ' THR . 59.6 Cg_endo -71.93 152.0 57.13 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.482 2.121 . . . . 0.0 112.324 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -108.1 -30.43 8.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.856 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 11.7 t . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.26 -0.876 . . . . 0.0 110.933 179.92 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 1.8 m . . . . . 0 N--CA 1.486 1.329 0 CA-C-O 120.751 0.31 . . . . 0.0 111.119 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.555 HD13 ' HA ' ' A' ' 12' ' ' ASP . 6.1 mm -121.09 135.65 60.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.1 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 70.8 m-70 -138.42 87.48 2.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.794 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 12.0 m -79.15 -53.37 7.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.985 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -114.68 11.35 16.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.116 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 56.01 23.57 6.88 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.335 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -115.79 -56.6 2.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.077 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 87.4 m -105.68 100.32 9.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.023 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 6.3 mt -68.83 128.63 32.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.728 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.2 m -119.59 150.36 49.9 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.207 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -59.18 147.8 88.89 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.631 2.221 . . . . 0.0 112.358 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.555 ' HA ' HD13 ' A' ' 2' ' ' ILE . 7.2 p-10 -58.66 -25.35 62.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.406 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -88.49 21.28 26.37 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.694 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.1 p -146.14 177.6 8.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.843 0.354 . . . . 0.0 111.194 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.42 ' O ' ' HA ' ' A' ' 26' ' ' CYS . 6.7 t -132.57 159.96 37.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.02 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.506 ' SG ' HG23 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -84.16 105.33 14.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.1 -179.864 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.654 ' HG ' ' HB2' ' A' ' 27' ' ' SER . 0.7 OUTLIER -118.35 139.65 51.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.491 179.655 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.4 mt -92.85 143.96 25.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.03 0.443 . . . . 0.0 111.328 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.7 164.04 18.34 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.403 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_exo -58.36 -4.8 1.88 Allowed 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.491 2.127 . . . . 0.0 112.812 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.403 ' HD2' HG23 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -117.61 21.53 12.92 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.799 0.333 . . . . 0.0 110.91 -179.741 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 62.91 44.36 97.54 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.534 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.403 HG23 ' HD2' ' A' ' 21' ' ' TYR . 54.2 t -113.0 132.55 61.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.755 0.312 . . . . 0.0 110.866 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 82.7 m95 -91.06 104.84 17.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.219 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 55.1 p90 -118.3 152.74 35.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.557 179.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.42 ' HA ' ' O ' ' A' ' 15' ' ' THR . 1.8 m -91.86 117.06 29.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.026 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.654 ' HB2' ' HG ' ' A' ' 17' ' ' SER . 0.1 OUTLIER -105.47 132.58 20.76 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.726 179.911 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -74.14 140.42 28.02 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.339 2.026 . . . . 0.0 112.515 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -139.39 178.28 7.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.905 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 23.0 t . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.188 -0.911 . . . . 0.0 110.851 179.949 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 26.9 m . . . . . 0 N--CA 1.485 1.315 0 CA-C-O 120.789 0.328 . . . . 0.0 111.062 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.534 ' HB ' ' HB2' ' A' ' 10' ' ' CYS . 12.6 mm -121.48 119.75 59.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.245 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.413 ' HD1' ' HA ' ' A' ' 6' ' ' ALA . 14.1 m-70 -126.62 85.17 2.35 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.72 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.2 m -72.26 -58.84 3.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.997 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -115.82 32.55 6.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.063 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.413 ' HA ' ' HD1' ' A' ' 3' ' ' HIS . . . 58.4 15.76 3.69 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.205 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -136.58 155.62 49.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.74 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 72.3 m 53.37 86.75 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.91 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 18.8 mt -71.21 130.6 35.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.092 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.534 ' HB2' ' HB ' ' A' ' 2' ' ' ILE . 13.0 m -112.29 155.08 44.13 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.809 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.474 ' HD2' ' HG1' ' A' ' 14' ' ' THR . 23.5 Cg_exo -64.41 139.97 67.59 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.516 2.144 . . . . 0.0 112.162 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -59.65 104.27 0.27 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.863 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 138.65 -12.12 3.44 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.473 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.474 ' HG1' ' HD2' ' A' ' 11' ' ' PRO . 47.5 p -108.04 161.52 14.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.763 0.316 . . . . 0.0 111.121 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.4 t -111.28 144.87 39.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.089 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -76.33 114.25 14.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.874 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.7 t -122.1 139.96 53.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.849 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.5 mt -95.06 125.73 39.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.899 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.25 159.91 81.2 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.774 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -54.04 -12.04 3.19 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.792 2.328 . . . . 0.0 112.851 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -105.19 -27.2 11.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.969 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 117.27 52.95 0.32 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.516 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 23.3 t -124.7 129.57 73.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.766 0.317 . . . . 0.0 111.042 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 92.7 m95 -82.78 99.24 9.56 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.04 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -116.36 151.7 35.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.727 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.426 ' HB3' ' OG1' ' A' ' 14' ' ' THR . 0.2 OUTLIER -89.18 127.36 35.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.247 -179.638 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -118.49 114.21 36.31 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.717 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -66.55 130.64 24.08 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.411 2.074 . . . . 0.0 112.194 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 12.7 p90 -113.11 178.15 4.38 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.849 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.177 -0.916 . . . . 0.0 110.874 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.4 ' H3 ' HG22 ' A' ' 1' ' ' VAL . 17.1 m . . . . . 0 N--CA 1.485 1.308 0 CA-C-O 120.775 0.322 . . . . 0.0 111.175 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.445 HG22 ' SG ' ' A' ' 4' ' ' CYS . 3.3 mm -101.3 145.22 11.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.114 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 26.1 m-70 -133.9 -33.6 1.04 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.915 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.445 ' SG ' HG22 ' A' ' 2' ' ' ILE . 0.4 OUTLIER 55.51 -94.05 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.164 179.894 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.406 ' H ' ' HB2' ' A' ' 4' ' ' CYS . 0.9 OUTLIER -94.37 30.71 1.89 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.8 0.333 . . . . 0.0 110.666 179.881 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 60.91 14.49 5.28 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.068 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -134.85 153.31 52.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.818 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 90.2 m 55.64 87.29 0.05 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.864 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 8.0 mt -69.28 146.88 12.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.151 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 7.0 m -138.74 157.58 71.64 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.832 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.509 ' HD2' ' HG1' ' A' ' 14' ' ' THR . 25.6 Cg_exo -62.97 145.74 94.5 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.485 2.123 . . . . 0.0 112.085 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -60.76 -21.3 62.88 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.11 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -85.3 14.15 51.66 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.663 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.509 ' HG1' ' HD2' ' A' ' 11' ' ' PRO . 66.5 p -140.47 171.08 14.63 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.819 0.343 . . . . 0.0 111.187 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 8.9 t -126.71 162.53 25.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.109 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -74.98 120.76 20.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.969 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -128.19 131.98 48.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.586 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.1 mt -91.84 124.98 36.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.886 0.374 . . . . 0.0 111.135 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.459 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 0.1 OUTLIER -78.95 162.38 64.98 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.522 179.702 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -56.12 -11.41 5.77 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.487 2.124 . . . . 0.0 112.616 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -113.76 26.2 10.56 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.072 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 59.01 59.07 11.44 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.587 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.459 ' HB ' ' HB2' ' A' ' 19' ' ' SER . 41.0 t -126.64 120.52 56.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.824 0.345 . . . . 0.0 111.282 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 94.7 m95 -81.25 99.62 8.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.902 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 56.0 p90 -117.82 161.75 19.22 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.926 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.427 ' HB3' ' OG1' ' A' ' 14' ' ' THR . 0.0 OUTLIER -87.07 129.0 35.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.092 -179.768 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.11 117.15 17.97 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.895 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -61.74 144.77 97.44 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.494 2.129 . . . . 0.0 112.215 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -113.0 157.81 21.05 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.869 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.363 -0.827 . . . . 0.0 110.985 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 2.9 m . . . . . 0 N--CA 1.485 1.316 0 CA-C-O 120.832 0.348 . . . . 0.0 111.148 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.554 HD11 ' HA ' ' A' ' 12' ' ' ASP . 3.0 mm -103.48 159.08 4.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.907 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 17.2 m-70 -137.25 -64.21 0.57 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.913 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.405 ' SG ' HG22 ' A' ' 2' ' ' ILE . 15.2 m 60.93 -86.4 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.194 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -74.73 -4.93 40.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.918 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 56.89 22.83 7.5 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.41 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -134.5 -21.46 1.76 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.024 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 42.8 m -130.46 94.26 3.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.972 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 10.8 mt -64.14 132.58 30.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.895 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.425 ' O ' HG12 ' A' ' 2' ' ' ILE . 6.4 m -120.27 153.33 55.72 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.164 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -56.59 142.88 90.2 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.603 2.202 . . . . 0.0 112.335 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.554 ' HA ' HD11 ' A' ' 2' ' ' ILE . 21.2 t0 -57.58 -24.28 55.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.379 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -92.69 21.47 38.74 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.884 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 82.2 p -141.28 173.77 11.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.902 0.382 . . . . 0.0 111.245 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.5 t -130.66 155.42 46.61 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.92 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -73.47 120.39 19.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.93 0.395 . . . . 0.0 110.986 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.6 t -132.18 135.92 46.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.52 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.1 mt -99.99 132.59 45.26 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.922 0.391 . . . . 0.0 111.073 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.557 ' HG ' ' H ' ' A' ' 21' ' ' TYR . 6.1 p -77.61 163.1 65.75 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.794 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.45 -6.43 4.17 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.592 2.195 . . . . 0.0 112.68 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.557 ' H ' ' HG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -117.1 20.57 13.7 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.813 0.339 . . . . 0.0 111.096 -179.735 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.52 47.58 76.69 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.903 -0.665 . . . . 0.0 113.009 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 51.8 t -117.6 117.15 54.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.765 0.317 . . . . 0.0 110.755 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -71.32 124.49 24.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.322 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 46.8 p90 -147.65 147.12 29.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.364 179.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -91.02 124.34 35.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.932 0.396 . . . . 0.0 111.275 -179.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 11.0 t -108.39 127.72 26.98 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.423 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -76.08 126.62 9.4 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.316 2.011 . . . . 0.0 112.445 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -101.07 -15.84 17.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.816 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 9.6 p . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.251 -0.881 . . . . 0.0 110.959 -179.909 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 6.1 m . . . . . 0 N--CA 1.485 1.315 0 CA-C-O 120.811 0.339 . . . . 0.0 111.024 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.649 ' HB ' ' HB2' ' A' ' 10' ' ' CYS . 4.7 mm -120.15 104.1 15.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.043 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 -95.49 74.96 3.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.919 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.414 ' HB2' ' HB ' ' A' ' 8' ' ' THR . 4.1 m -62.73 113.06 2.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.85 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 59.98 18.19 7.35 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.088 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 55.69 26.26 9.14 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.381 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -137.95 -2.07 1.93 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.253 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.414 ' HB ' ' HB2' ' A' ' 4' ' ' CYS . 21.7 m -143.28 108.3 4.95 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.285 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 5.8 mt -84.44 143.32 11.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.869 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.649 ' HB2' ' HB ' ' A' ' 2' ' ' ILE . 12.3 m -145.8 154.62 51.8 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.203 -179.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -57.86 143.5 95.63 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.536 2.158 . . . . 0.0 112.21 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -54.83 -31.77 59.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.282 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -85.15 23.33 8.21 Favored Glycine 0 CA--C 1.518 0.276 0 C-N-CA 120.892 -0.67 . . . . 0.0 113.253 -179.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 81.6 p -142.61 165.07 28.4 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.835 0.35 . . . . 0.0 111.259 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 8.2 t -124.69 164.1 20.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.018 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.52 ' SG ' HG21 ' A' ' 2' ' ' ILE . 3.6 m -80.47 118.76 22.36 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.259 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.548 ' HG ' ' HB3' ' A' ' 27' ' ' SER . 1.9 m -125.49 140.66 52.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.365 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.0 mt -94.28 131.92 39.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.011 0.434 . . . . 0.0 111.467 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.63 163.83 34.26 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.411 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -56.62 -8.36 2.84 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.549 2.166 . . . . 0.0 112.665 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -115.82 25.84 10.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.024 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 58.91 35.43 82.99 Favored Glycine 0 C--N 1.33 0.201 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.684 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 59.3 t -105.45 124.9 60.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.872 0.368 . . . . 0.0 111.039 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 80.9 m95 -82.29 112.33 19.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.205 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 49.3 p90 -125.18 154.0 42.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.682 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -86.44 129.12 34.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.923 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.548 ' HB3' ' HG ' ' A' ' 17' ' ' SER . 28.1 t -130.96 125.33 21.17 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.03 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 27' ' ' SER . 16.3 Cg_exo -68.35 149.35 75.25 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.753 2.302 . . . . 0.0 112.204 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -104.99 -19.37 13.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.93 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 29.0 t . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.213 -0.899 . . . . 0.0 111.107 -179.959 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 3.9 m . . . . . 0 N--CA 1.485 1.314 0 CA-C-O 120.835 0.35 . . . . 0.0 111.172 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.785 ' HB ' ' HB2' ' A' ' 10' ' ' CYS . 5.2 mm -92.27 129.27 43.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.245 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 16.8 m-70 -121.61 -44.13 2.35 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.088 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.586 ' SG ' HG22 ' A' ' 2' ' ' ILE . 0.7 OUTLIER 58.8 -90.84 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.5 179.875 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -79.61 2.51 22.15 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.088 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 58.23 16.76 4.17 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.364 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -100.98 -36.24 9.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.85 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 14.8 t -125.33 159.67 31.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.915 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 44.0 mt -111.1 142.59 23.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.93 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.785 ' HB2' ' HB ' ' A' ' 2' ' ' ILE . 56.4 m -134.43 157.22 77.89 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.905 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -76.38 141.33 22.69 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.308 2.006 . . . . 0.0 112.167 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -55.43 99.96 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.116 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 140.59 -4.79 2.53 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.471 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.419 ' O ' HG13 ' A' ' 2' ' ' ILE . 12.2 p -113.12 151.31 30.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.726 0.298 . . . . 0.0 110.867 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.2 t -105.21 152.73 22.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.281 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -76.21 112.49 12.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.646 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -120.69 141.74 50.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.078 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.525 HD21 ' HA2' ' A' ' 22' ' ' GLY . 6.6 mt -97.65 125.79 42.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.799 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.439 ' HB3' ' HB ' ' A' ' 23' ' ' VAL . 0.3 OUTLIER -77.6 164.06 60.11 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.785 -179.89 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.448 ' HG2' ' CZ ' ' A' ' 21' ' ' TYR . 9.5 Cg_endo -54.6 -12.08 3.97 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 122.742 2.295 . . . . 0.0 112.691 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.448 ' CZ ' ' HG2' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -117.57 30.11 7.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.035 -179.518 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.525 ' HA2' HD21 ' A' ' 18' ' ' LEU . . . 56.8 48.81 75.25 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.568 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.439 ' HB ' ' HB3' ' A' ' 19' ' ' SER . 16.2 t -113.46 117.15 54.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.795 0.331 . . . . 0.0 111.066 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -76.07 105.06 6.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.209 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -123.47 156.48 35.49 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.834 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 1.6 m -87.95 108.28 19.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.224 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -94.55 117.38 66.99 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.632 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.35 127.33 13.22 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.467 2.111 . . . . 0.0 112.484 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -119.21 -21.63 7.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.006 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.877 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.491 HG21 HG22 ' A' ' 9' ' ' ILE . 16.0 m . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.822 0.344 . . . . 0.0 111.145 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.424 HG22 ' SG ' ' A' ' 16' ' ' CYS . 13.3 mm -84.35 116.74 28.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.104 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.416 ' HD1' ' HA ' ' A' ' 6' ' ' ALA . 1.2 m-70 -94.17 -48.76 6.06 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.025 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 63.54 -84.35 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.207 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 20.0 p-10 -86.33 9.62 17.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.151 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.416 ' HA ' ' HD1' ' A' ' 3' ' ' HIS . . . 55.09 29.38 12.39 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.237 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -137.27 -31.46 0.81 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.244 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.4 m -112.26 118.55 35.59 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.271 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.491 HG22 HG21 ' A' ' 1' ' ' VAL . 2.6 mp -88.69 142.16 13.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.845 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.415 ' HB3' ' OG1' ' A' ' 14' ' ' THR . 20.5 m -105.37 152.63 39.93 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.395 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.48 ' O ' ' HB2' ' A' ' 12' ' ' ASP . 10.8 Cg_exo -73.38 18.69 0.39 Allowed 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 123.09 2.526 . . . . 0.0 112.958 -179.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.48 ' HB2' ' O ' ' A' ' 11' ' ' PRO . 21.5 m-20 69.65 138.14 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.034 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 78.18 22.41 68.25 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.194 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.485 ' OG1' ' HB3' ' A' ' 26' ' ' CYS . 70.5 p -129.26 175.02 9.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.83 0.348 . . . . 0.0 111.185 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.9 t -128.79 152.95 47.9 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.01 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.424 ' SG ' HG22 ' A' ' 2' ' ' ILE . 1.7 m -72.7 112.5 8.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.164 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -127.75 136.93 52.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.657 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.2 mt -91.57 150.22 21.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.076 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.425 ' HG ' ' H ' ' A' ' 21' ' ' TYR . 1.1 p -94.05 161.35 30.02 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.791 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -55.73 -13.91 9.38 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.553 2.169 . . . . 0.0 112.511 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.425 ' H ' ' HG ' ' A' ' 19' ' ' SER . 0.1 OUTLIER -102.93 -22.03 13.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.848 -179.723 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 113.29 28.64 3.24 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.633 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.432 HG13 ' N ' ' A' ' 24' ' ' TRP . 48.5 t -96.96 140.02 18.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.803 0.335 . . . . 0.0 110.947 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.432 ' N ' HG13 ' A' ' 23' ' ' VAL . 67.3 m95 -93.08 103.42 15.72 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.261 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 55.3 p90 -119.66 168.32 11.16 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.318 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.485 ' HB3' ' OG1' ' A' ' 14' ' ' THR . 15.6 m -107.85 138.13 44.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.927 0.394 . . . . 0.0 111.441 -179.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.8 m -125.73 118.72 24.29 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.697 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.459 ' HA ' ' HA ' ' A' ' 14' ' ' THR . 19.9 Cg_exo -65.49 135.3 41.88 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.577 2.184 . . . . 0.0 112.321 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 28.1 p90 -118.82 167.72 11.44 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.049 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.179 -0.915 . . . . 0.0 111.073 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 13.6 m . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.796 0.331 . . . . 0.0 111.105 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 12.2 mm -78.33 137.2 22.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.239 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.404 ' CE1' HG12 ' A' ' 9' ' ' ILE . 9.8 m-70 -120.83 -47.46 2.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.847 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 60.94 -87.1 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.38 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.66 -0.0 19.17 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.004 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 59.71 23.14 11.97 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.005 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -120.55 -45.12 2.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.932 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.3 t -104.31 152.47 22.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.933 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.404 HG12 ' CE1' ' A' ' 3' ' ' HIS . 17.9 mt -111.52 136.4 47.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.808 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 16.9 m -137.24 162.13 57.1 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.006 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.405 ' HG2' ' OG1' ' A' ' 14' ' ' THR . 36.8 Cg_endo -66.38 147.18 82.5 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.128 1.886 . . . . 0.0 111.934 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -64.07 -7.72 9.62 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.411 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -104.62 27.51 18.74 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.839 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.598 ' HG1' ' HB3' ' A' ' 26' ' ' CYS . 36.7 p -142.78 173.94 11.1 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.896 0.379 . . . . 0.0 111.258 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 10.0 t -126.33 160.11 31.3 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.025 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -74.04 111.53 9.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.715 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -116.68 136.19 53.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.03 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.8 mt -98.37 125.3 43.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.935 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.691 ' HB3' ' HB ' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -80.93 163.96 53.12 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.741 179.995 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.454 ' HG2' ' CE1' ' A' ' 21' ' ' TYR . 9.3 Cg_endo -54.12 -12.38 3.62 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.787 2.325 . . . . 0.0 112.692 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.454 ' CE1' ' HG2' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -116.78 32.47 6.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.927 -179.594 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 54.53 55.3 27.76 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.568 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.691 ' HB ' ' HB3' ' A' ' 19' ' ' SER . 40.7 t -116.02 123.84 71.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.824 0.345 . . . . 0.0 111.345 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 97.0 m95 -85.41 93.18 8.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.76 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -113.66 162.23 16.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.048 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.598 ' HB3' ' HG1' ' A' ' 14' ' ' THR . 0.0 OUTLIER -85.28 119.49 25.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.11 -179.68 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.419 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 4.8 t -111.19 116.19 51.59 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.904 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 27' ' ' SER . 7.4 Cg_exo -73.08 128.32 12.95 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.833 2.355 . . . . 0.0 112.275 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -101.31 -0.28 35.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.028 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.5 m . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.928 179.993 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 13.4 m . . . . . 0 N--CA 1.485 1.31 0 CA-C-O 120.765 0.317 . . . . 0.0 111.155 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.778 ' HB ' ' HB2' ' A' ' 10' ' ' CYS . 3.8 mp -117.3 113.49 42.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.977 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 13.3 m80 -102.62 -45.37 5.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.806 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 58.81 -90.13 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.218 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -79.84 4.09 17.63 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.946 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 56.77 27.48 12.84 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.96 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -129.49 -14.14 4.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.104 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.25 123.96 14.15 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.192 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 7.5 mt -86.58 154.99 3.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.992 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.778 ' HB2' ' HB ' ' A' ' 2' ' ' ILE . 22.9 m -144.68 153.14 54.26 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.065 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -63.56 141.39 79.95 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.424 2.083 . . . . 0.0 112.022 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -59.52 104.13 0.25 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.684 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 134.1 0.49 3.82 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.466 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.414 ' O ' HG12 ' A' ' 2' ' ' ILE . 43.6 p -116.97 153.96 31.71 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.822 0.344 . . . . 0.0 111.179 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.424 HG22 ' O ' ' A' ' 27' ' ' SER . 10.1 t -105.31 156.06 18.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.142 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -82.18 113.14 19.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.663 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.1 m -124.65 132.7 53.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.9 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.414 HD23 ' HA ' ' A' ' 18' ' ' LEU . 5.2 mt -89.02 136.47 33.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.022 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -83.15 160.42 60.16 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.513 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -58.07 -11.95 11.45 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.464 2.109 . . . . 0.0 112.529 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.6 24.01 12.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.779 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 62.8 52.64 46.86 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 121.045 -0.598 . . . . 0.0 112.647 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.7 t -124.02 114.76 42.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.726 0.298 . . . . 0.0 110.766 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -72.78 121.09 19.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.064 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 54.9 p90 -137.65 153.68 49.82 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.888 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -90.03 125.64 35.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.093 -179.65 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.424 ' O ' HG22 ' A' ' 15' ' ' THR . 3.2 t -114.98 118.98 39.83 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.783 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.14 139.73 56.73 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.398 2.065 . . . . 0.0 112.465 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 42.9 p90 . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.889 179.921 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 1.6 m . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.753 0.311 . . . . 0.0 111.08 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.729 ' HB ' ' HB2' ' A' ' 10' ' ' CYS . 7.5 mm -109.07 121.69 62.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.507 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 10.3 m170 -121.26 119.92 33.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.273 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.2 m -120.29 -18.21 8.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.654 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -146.72 7.85 0.97 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.641 0.258 . . . . 0.0 111.248 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 55.91 21.46 4.91 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.214 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -124.03 -51.76 1.78 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.961 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.2 m -105.45 92.44 4.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.965 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 22.4 mt -67.92 137.06 25.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.22 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.729 ' HB2' ' HB ' ' A' ' 2' ' ' ILE . 9.5 m -117.04 159.52 40.74 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.775 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -79.05 145.7 19.68 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.34 2.027 . . . . 0.0 111.992 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -61.53 109.59 1.22 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.872 0.368 . . . . 0.0 110.844 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 130.12 14.64 1.99 Allowed Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.635 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.1 p -139.11 154.07 48.09 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.749 0.309 . . . . 0.0 111.156 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.1 t -104.27 153.06 21.46 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.177 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.2 m -73.61 114.01 11.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.055 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.432 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 0.4 OUTLIER -120.87 129.99 53.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.596 179.773 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.4 mt -94.46 140.01 30.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.888 0.375 . . . . 0.0 111.181 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.562 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 0.1 OUTLIER -86.77 162.03 45.82 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.532 179.805 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.31 -8.06 6.12 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.458 2.105 . . . . 0.0 112.714 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -118.05 23.68 11.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.824 0.345 . . . . 0.0 111.094 -179.655 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.28 46.77 85.66 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.673 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.562 ' HB ' ' HB2' ' A' ' 19' ' ' SER . 60.6 t -113.82 117.73 56.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.805 0.336 . . . . 0.0 110.74 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 87.5 m95 -77.78 117.06 18.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.35 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.432 ' CE2' ' HB3' ' A' ' 17' ' ' SER . 53.8 p90 -137.98 147.22 44.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.501 179.241 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -85.31 122.81 30.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.096 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 24.9 t -116.03 125.5 28.55 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.033 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -71.93 152.0 57.13 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.482 2.121 . . . . 0.0 112.324 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.856 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 1' ' ' VAL . . . . . 0.408 ' HB ' ' H ' ' A' ' 2' ' ' ILE . 1.8 m . . . . . 0 N--CA 1.486 1.329 0 CA-C-O 120.751 0.31 . . . . 0.0 111.119 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.658 HD11 ' HA ' ' A' ' 12' ' ' ASP . 6.1 mm -121.09 135.65 60.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.1 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 70.8 m-70 -138.42 87.48 2.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.794 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 12.0 m -79.15 -53.37 7.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.985 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -114.68 11.35 16.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.116 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 56.01 23.57 6.88 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.335 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -115.79 -56.6 2.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.077 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 87.4 m -105.68 100.32 9.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.023 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.407 ' H ' HG13 ' A' ' 9' ' ' ILE . 6.3 mt -68.83 128.63 32.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.728 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.2 m -119.59 150.36 49.9 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.207 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -59.18 147.8 88.89 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.631 2.221 . . . . 0.0 112.358 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.658 ' HA ' HD11 ' A' ' 2' ' ' ILE . 7.2 p-10 -58.66 -25.35 62.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.406 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -88.49 21.28 26.37 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.694 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.1 p -146.14 177.6 8.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.843 0.354 . . . . 0.0 111.194 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.443 HG22 ' O ' ' A' ' 27' ' ' SER . 6.7 t -132.57 159.96 37.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.02 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -84.16 105.33 14.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.1 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -118.35 139.65 51.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.491 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.424 HD23 ' HA ' ' A' ' 18' ' ' LEU . 8.4 mt -92.85 143.96 25.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.03 0.443 . . . . 0.0 111.328 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.7 164.04 18.34 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.403 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_exo -58.36 -4.8 1.88 Allowed 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.491 2.127 . . . . 0.0 112.812 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -117.61 21.53 12.92 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.799 0.333 . . . . 0.0 110.91 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 62.91 44.36 97.54 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.534 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 54.2 t -113.0 132.55 61.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.755 0.312 . . . . 0.0 110.866 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 82.7 m95 -91.06 104.84 17.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.219 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 55.1 p90 -118.3 152.74 35.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.557 179.464 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.433 ' HA ' ' O ' ' A' ' 15' ' ' THR . 1.8 m -91.86 117.06 29.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.026 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.443 ' O ' HG22 ' A' ' 15' ' ' THR . 0.1 OUTLIER -105.47 132.58 20.76 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.726 179.911 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -74.14 140.42 28.02 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.339 2.026 . . . . 0.0 112.515 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 55.4 p90 . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.905 179.771 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 26.9 m . . . . . 0 N--CA 1.485 1.315 0 CA-C-O 120.789 0.328 . . . . 0.0 111.062 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.571 ' HB ' ' HB2' ' A' ' 10' ' ' CYS . 12.6 mm -121.48 119.75 59.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.245 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -126.62 85.17 2.35 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.72 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.2 m -72.26 -58.84 3.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.997 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -115.82 32.55 6.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.063 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 58.4 15.76 3.69 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.205 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -136.58 155.62 49.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.74 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 72.3 m 53.37 86.75 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.91 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 18.8 mt -71.21 130.6 35.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.092 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.571 ' HB2' ' HB ' ' A' ' 2' ' ' ILE . 13.0 m -112.29 155.08 44.13 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.809 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -64.41 139.97 67.59 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.516 2.144 . . . . 0.0 112.162 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -59.65 104.27 0.27 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.863 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 138.65 -12.12 3.44 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.473 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.445 ' OG1' ' HB3' ' A' ' 26' ' ' CYS . 47.5 p -108.04 161.52 14.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.763 0.316 . . . . 0.0 111.121 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.469 HG22 ' O ' ' A' ' 27' ' ' SER . 6.4 t -111.28 144.87 39.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.089 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -76.33 114.25 14.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.874 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.7 t -122.1 139.96 53.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.849 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.441 HD23 ' HA ' ' A' ' 18' ' ' LEU . 6.5 mt -95.06 125.73 39.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.899 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.25 159.91 81.2 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.774 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -54.04 -12.04 3.19 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.792 2.328 . . . . 0.0 112.851 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -105.19 -27.2 11.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.969 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 117.27 52.95 0.32 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.516 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 23.3 t -124.7 129.57 73.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.766 0.317 . . . . 0.0 111.042 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 92.7 m95 -82.78 99.24 9.56 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.04 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -116.36 151.7 35.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.727 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.445 ' HB3' ' OG1' ' A' ' 14' ' ' THR . 0.2 OUTLIER -89.18 127.36 35.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.247 -179.638 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.469 ' O ' HG22 ' A' ' 15' ' ' THR . 0.4 OUTLIER -118.49 114.21 36.31 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.717 179.778 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -66.55 130.64 24.08 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.411 2.074 . . . . 0.0 112.194 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 12.7 p90 . . . . . 0 C--N 1.328 -0.365 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.849 179.799 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 17.1 m . . . . . 0 N--CA 1.485 1.308 0 CA-C-O 120.775 0.322 . . . . 0.0 111.175 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.586 HD11 ' HA ' ' A' ' 12' ' ' ASP . 3.3 mm -101.3 145.22 11.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.114 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 26.1 m-70 -133.9 -33.6 1.04 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.915 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.446 ' HB2' ' H ' ' A' ' 5' ' ' ASP . 0.4 OUTLIER 55.51 -94.05 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.164 179.894 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.446 ' H ' ' HB2' ' A' ' 4' ' ' CYS . 0.9 OUTLIER -94.37 30.71 1.89 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.8 0.333 . . . . 0.0 110.666 179.881 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 60.91 14.49 5.28 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.068 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -134.85 153.31 52.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.818 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 90.2 m 55.64 87.29 0.05 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.864 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 8.0 mt -69.28 146.88 12.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.151 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 7.0 m -138.74 157.58 71.64 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.832 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -62.97 145.74 94.5 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.485 2.123 . . . . 0.0 112.085 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.586 ' HA ' HD11 ' A' ' 2' ' ' ILE . 3.3 p-10 -60.76 -21.3 62.88 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.11 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -85.3 14.15 51.66 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.663 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.449 ' OG1' ' HB3' ' A' ' 26' ' ' CYS . 66.5 p -140.47 171.08 14.63 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.819 0.343 . . . . 0.0 111.187 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.48 HG22 ' O ' ' A' ' 27' ' ' SER . 8.9 t -126.71 162.53 25.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.109 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -74.98 120.76 20.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.969 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -128.19 131.98 48.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.586 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.438 HD23 ' HA ' ' A' ' 18' ' ' LEU . 6.1 mt -91.84 124.98 36.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.886 0.374 . . . . 0.0 111.135 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.49 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 0.1 OUTLIER -78.95 162.38 64.98 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.522 179.702 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -56.12 -11.41 5.77 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.487 2.124 . . . . 0.0 112.616 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -113.76 26.2 10.56 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.072 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 59.01 59.07 11.44 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.587 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.49 ' HB ' ' HB2' ' A' ' 19' ' ' SER . 41.0 t -126.64 120.52 56.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.824 0.345 . . . . 0.0 111.282 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 94.7 m95 -81.25 99.62 8.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.902 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 56.0 p90 -117.82 161.75 19.22 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.926 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.449 ' HB3' ' OG1' ' A' ' 14' ' ' THR . 0.0 OUTLIER -87.07 129.0 35.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.092 -179.768 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.48 ' O ' HG22 ' A' ' 15' ' ' THR . 0.1 OUTLIER -130.11 117.15 17.97 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.895 -179.991 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -61.74 144.77 97.44 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.494 2.129 . . . . 0.0 112.215 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.33 -0.24 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.869 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 2.9 m . . . . . 0 N--CA 1.485 1.316 0 CA-C-O 120.832 0.348 . . . . 0.0 111.148 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.513 HD11 ' HA ' ' A' ' 12' ' ' ASP . 3.0 mm -103.48 159.08 4.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.907 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 17.2 m-70 -137.25 -64.21 0.57 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.913 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 15.2 m 60.93 -86.4 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.194 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -74.73 -4.93 40.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.918 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 56.89 22.83 7.5 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.41 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -134.5 -21.46 1.76 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.024 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 42.8 m -130.46 94.26 3.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.972 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 10.8 mt -64.14 132.58 30.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.895 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.446 ' O ' HG12 ' A' ' 2' ' ' ILE . 6.4 m -120.27 153.33 55.72 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.164 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -56.59 142.88 90.2 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.603 2.202 . . . . 0.0 112.335 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.513 ' HA ' HD11 ' A' ' 2' ' ' ILE . 21.2 t0 -57.58 -24.28 55.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.379 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -92.69 21.47 38.74 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.884 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 82.2 p -141.28 173.77 11.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.902 0.382 . . . . 0.0 111.245 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.5 t -130.66 155.42 46.61 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.92 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -73.47 120.39 19.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.93 0.395 . . . . 0.0 110.986 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.6 t -132.18 135.92 46.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.52 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.1 mt -99.99 132.59 45.26 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.922 0.391 . . . . 0.0 111.073 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 6.1 p -77.61 163.1 65.75 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.794 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.45 -6.43 4.17 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.592 2.195 . . . . 0.0 112.68 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -117.1 20.57 13.7 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.813 0.339 . . . . 0.0 111.096 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.52 47.58 76.69 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.903 -0.665 . . . . 0.0 113.009 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 51.8 t -117.6 117.15 54.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.765 0.317 . . . . 0.0 110.755 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -71.32 124.49 24.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.322 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 46.8 p90 -147.65 147.12 29.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.364 179.44 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -91.02 124.34 35.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.932 0.396 . . . . 0.0 111.275 -179.571 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 11.0 t -108.39 127.72 26.98 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.423 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -76.08 126.62 9.4 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.316 2.011 . . . . 0.0 112.445 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.816 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 6.1 m . . . . . 0 N--CA 1.485 1.315 0 CA-C-O 120.811 0.339 . . . . 0.0 111.024 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.68 ' HB ' ' HB2' ' A' ' 10' ' ' CYS . 4.7 mm -120.15 104.1 15.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.043 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 -95.49 74.96 3.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.919 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.421 ' HB2' ' HB ' ' A' ' 8' ' ' THR . 4.1 m -62.73 113.06 2.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.85 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 59.98 18.19 7.35 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.088 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 55.69 26.26 9.14 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.381 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -137.95 -2.07 1.93 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.253 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.421 ' HB ' ' HB2' ' A' ' 4' ' ' CYS . 21.7 m -143.28 108.3 4.95 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.285 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 5.8 mt -84.44 143.32 11.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.869 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.68 ' HB2' ' HB ' ' A' ' 2' ' ' ILE . 12.3 m -145.8 154.62 51.8 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.203 -179.568 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -57.86 143.5 95.63 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.536 2.158 . . . . 0.0 112.21 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -54.83 -31.77 59.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.282 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -85.15 23.33 8.21 Favored Glycine 0 CA--C 1.518 0.276 0 C-N-CA 120.892 -0.67 . . . . 0.0 113.253 -179.495 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 81.6 p -142.61 165.07 28.4 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.835 0.35 . . . . 0.0 111.259 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.448 HG22 ' O ' ' A' ' 27' ' ' SER . 8.2 t -124.69 164.1 20.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.018 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 3.6 m -80.47 118.76 22.36 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.259 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.9 m -125.49 140.66 52.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.365 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.439 HD23 ' HA ' ' A' ' 18' ' ' LEU . 7.0 mt -94.28 131.92 39.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.011 0.434 . . . . 0.0 111.467 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.63 163.83 34.26 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.411 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -56.62 -8.36 2.84 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.549 2.166 . . . . 0.0 112.665 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -115.82 25.84 10.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.024 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 58.91 35.43 82.99 Favored Glycine 0 C--N 1.33 0.201 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.684 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 59.3 t -105.45 124.9 60.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.872 0.368 . . . . 0.0 111.039 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 80.9 m95 -82.29 112.33 19.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.205 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 49.3 p90 -125.18 154.0 42.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.682 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -86.44 129.12 34.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.923 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.448 ' O ' HG22 ' A' ' 15' ' ' THR . 28.1 t -130.96 125.33 21.17 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.03 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 27' ' ' SER . 16.3 Cg_exo -68.35 149.35 75.25 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.753 2.302 . . . . 0.0 112.204 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.93 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 3.9 m . . . . . 0 N--CA 1.485 1.314 0 CA-C-O 120.835 0.35 . . . . 0.0 111.172 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.819 ' HB ' ' HB2' ' A' ' 10' ' ' CYS . 5.2 mm -92.27 129.27 43.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.245 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 16.8 m-70 -121.61 -44.13 2.35 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.088 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.566 ' SG ' HG22 ' A' ' 2' ' ' ILE . 0.7 OUTLIER 58.8 -90.84 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.5 179.875 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.48 ' H ' ' HB2' ' A' ' 4' ' ' CYS . 0.8 OUTLIER -79.61 2.51 22.15 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.088 -179.649 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 58.23 16.76 4.17 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.364 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -100.98 -36.24 9.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.85 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 14.8 t -125.33 159.67 31.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.915 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 44.0 mt -111.1 142.59 23.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.93 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.819 ' HB2' ' HB ' ' A' ' 2' ' ' ILE . 56.4 m -134.43 157.22 77.89 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.905 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -76.38 141.33 22.69 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.308 2.006 . . . . 0.0 112.167 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -55.43 99.96 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.116 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 140.59 -4.79 2.53 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.471 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.421 ' O ' HG13 ' A' ' 2' ' ' ILE . 12.2 p -113.12 151.31 30.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.726 0.298 . . . . 0.0 110.867 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.2 t -105.21 152.73 22.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.281 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -76.21 112.49 12.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.646 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -120.69 141.74 50.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.078 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.551 HD22 ' HA2' ' A' ' 22' ' ' GLY . 6.6 mt -97.65 125.79 42.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.799 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.44 ' HB3' ' HB ' ' A' ' 23' ' ' VAL . 0.3 OUTLIER -77.6 164.06 60.11 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.785 -179.89 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.466 ' HG2' ' CZ ' ' A' ' 21' ' ' TYR . 9.5 Cg_endo -54.6 -12.08 3.97 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 122.742 2.295 . . . . 0.0 112.691 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.466 ' CZ ' ' HG2' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -117.57 30.11 7.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.035 -179.518 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.551 ' HA2' HD22 ' A' ' 18' ' ' LEU . . . 56.8 48.81 75.25 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.568 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.44 ' HB ' ' HB3' ' A' ' 19' ' ' SER . 16.2 t -113.46 117.15 54.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.795 0.331 . . . . 0.0 111.066 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -76.07 105.06 6.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.209 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -123.47 156.48 35.49 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.834 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 1.6 m -87.95 108.28 19.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.224 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -94.55 117.38 66.99 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.632 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.35 127.33 13.22 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.467 2.111 . . . . 0.0 112.484 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 50.0 p90 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.006 179.952 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 16.0 m . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.822 0.344 . . . . 0.0 111.145 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 13.3 mm -84.35 116.74 28.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.104 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -94.17 -48.76 6.06 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.025 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 63.54 -84.35 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.207 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.438 ' OD2' ' HB3' ' A' ' 7' ' ' ALA . 20.0 p-10 -86.33 9.62 17.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.151 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 55.09 29.38 12.39 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.237 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.438 ' HB3' ' OD2' ' A' ' 5' ' ' ASP . . . -137.27 -31.46 0.81 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.244 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.4 m -112.26 118.55 35.59 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.271 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.6 mp -88.69 142.16 13.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.845 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.408 ' HB3' ' OG1' ' A' ' 14' ' ' THR . 20.5 m -105.37 152.63 39.93 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.395 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.48 ' O ' ' HB2' ' A' ' 12' ' ' ASP . 10.8 Cg_exo -73.38 18.69 0.39 Allowed 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 123.09 2.526 . . . . 0.0 112.958 -179.615 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.48 ' HB2' ' O ' ' A' ' 11' ' ' PRO . 21.5 m-20 69.65 138.14 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.034 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 78.18 22.41 68.25 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.194 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.497 ' OG1' ' HB3' ' A' ' 26' ' ' CYS . 70.5 p -129.26 175.02 9.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.83 0.348 . . . . 0.0 111.185 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.546 HG22 ' O ' ' A' ' 27' ' ' SER . 9.9 t -128.79 152.95 47.9 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.01 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.7 m -72.7 112.5 8.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.164 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -127.75 136.93 52.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.657 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.2 mt -91.57 150.22 21.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.076 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.1 p -94.05 161.35 30.02 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.791 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -55.73 -13.91 9.38 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.553 2.169 . . . . 0.0 112.511 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -102.93 -22.03 13.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.848 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 113.29 28.64 3.24 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.633 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 48.5 t -96.96 140.02 18.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.803 0.335 . . . . 0.0 110.947 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 67.3 m95 -93.08 103.42 15.72 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.261 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 55.3 p90 -119.66 168.32 11.16 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.318 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.497 ' HB3' ' OG1' ' A' ' 14' ' ' THR . 15.6 m -107.85 138.13 44.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.927 0.394 . . . . 0.0 111.441 -179.498 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.546 ' O ' HG22 ' A' ' 15' ' ' THR . 4.8 m -125.73 118.72 24.29 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.697 179.703 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.493 ' HA ' ' HA ' ' A' ' 14' ' ' THR . 19.9 Cg_exo -65.49 135.3 41.88 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.577 2.184 . . . . 0.0 112.321 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 28.1 p90 . . . . . 0 C--N 1.331 -0.229 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.049 179.921 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 13.6 m . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.796 0.331 . . . . 0.0 111.105 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 12.2 mm -78.33 137.2 22.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.239 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 2.7 m80 -120.83 -47.46 2.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.847 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 60.94 -87.1 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.38 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.66 -0.0 19.17 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.004 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 59.71 23.14 11.97 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.005 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -120.55 -45.12 2.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.932 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.3 t -104.31 152.47 22.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.933 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 17.9 mt -111.52 136.4 47.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.808 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 16.9 m -137.24 162.13 57.1 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.006 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.405 ' HG2' ' OG1' ' A' ' 14' ' ' THR . 36.8 Cg_endo -66.38 147.18 82.5 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.128 1.886 . . . . 0.0 111.934 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -64.07 -7.72 9.62 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.411 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -104.62 27.51 18.74 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.839 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.405 ' OG1' ' HG2' ' A' ' 11' ' ' PRO . 36.7 p -142.78 173.94 11.1 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.896 0.379 . . . . 0.0 111.258 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 10.0 t -126.33 160.11 31.3 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.025 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -74.04 111.53 9.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.715 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -116.68 136.19 53.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.03 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.557 HD22 ' HA2' ' A' ' 22' ' ' GLY . 5.8 mt -98.37 125.3 43.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.935 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.698 ' HB3' ' HB ' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -80.93 163.96 53.12 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.741 179.995 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.465 ' HG2' ' CE1' ' A' ' 21' ' ' TYR . 9.3 Cg_endo -54.12 -12.38 3.62 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.787 2.325 . . . . 0.0 112.692 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.465 ' CE1' ' HG2' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -116.78 32.47 6.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.927 -179.594 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.557 ' HA2' HD22 ' A' ' 18' ' ' LEU . . . 54.53 55.3 27.76 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.568 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.698 ' HB ' ' HB3' ' A' ' 19' ' ' SER . 40.7 t -116.02 123.84 71.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.824 0.345 . . . . 0.0 111.345 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 97.0 m95 -85.41 93.18 8.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.76 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -113.66 162.23 16.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.048 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -85.28 119.49 25.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.11 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.433 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 4.8 t -111.19 116.19 51.59 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.904 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 27' ' ' SER . 7.4 Cg_exo -73.08 128.32 12.95 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.833 2.355 . . . . 0.0 112.275 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 1.9 p90 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.028 179.953 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 13.4 m . . . . . 0 N--CA 1.485 1.31 0 CA-C-O 120.765 0.317 . . . . 0.0 111.155 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.778 ' HB ' ' HB2' ' A' ' 10' ' ' CYS . 3.8 mp -117.3 113.49 42.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.977 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 13.3 m80 -102.62 -45.37 5.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.806 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 58.81 -90.13 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.218 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -79.84 4.09 17.63 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.946 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 56.77 27.48 12.84 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.96 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -129.49 -14.14 4.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.104 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.25 123.96 14.15 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.192 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 7.5 mt -86.58 154.99 3.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.992 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.778 ' HB2' ' HB ' ' A' ' 2' ' ' ILE . 22.9 m -144.68 153.14 54.26 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.065 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -63.56 141.39 79.95 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.424 2.083 . . . . 0.0 112.022 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -59.52 104.13 0.25 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.684 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 134.1 0.49 3.82 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.466 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.414 ' O ' HG12 ' A' ' 2' ' ' ILE . 43.6 p -116.97 153.96 31.71 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.822 0.344 . . . . 0.0 111.179 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.424 HG22 ' O ' ' A' ' 27' ' ' SER . 10.1 t -105.31 156.06 18.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.142 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -82.18 113.14 19.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.663 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.1 m -124.65 132.7 53.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.9 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.414 HD23 ' HA ' ' A' ' 18' ' ' LEU . 5.2 mt -89.02 136.47 33.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.022 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -83.15 160.42 60.16 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.513 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -58.07 -11.95 11.45 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.464 2.109 . . . . 0.0 112.529 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.6 24.01 12.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.779 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 62.8 52.64 46.86 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 121.045 -0.598 . . . . 0.0 112.647 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.7 t -124.02 114.76 42.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.726 0.298 . . . . 0.0 110.766 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -72.78 121.09 19.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.064 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 54.9 p90 -137.65 153.68 49.82 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.888 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -90.03 125.64 35.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.093 -179.65 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.424 ' O ' HG22 ' A' ' 15' ' ' THR . 3.2 t -114.98 118.98 39.83 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.783 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.14 139.73 56.73 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.398 2.065 . . . . 0.0 112.465 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 42.9 p90 -137.12 167.46 21.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.889 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 12.2 t . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.882 179.994 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 1.6 m . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.753 0.311 . . . . 0.0 111.08 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.729 ' HB ' ' HB2' ' A' ' 10' ' ' CYS . 7.5 mm -109.07 121.69 62.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.507 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 10.3 m170 -121.26 119.92 33.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.273 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.2 m -120.29 -18.21 8.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.654 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -146.72 7.85 0.97 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.641 0.258 . . . . 0.0 111.248 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 55.91 21.46 4.91 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.214 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -124.03 -51.76 1.78 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.961 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.2 m -105.45 92.44 4.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.965 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 22.4 mt -67.92 137.06 25.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.22 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.729 ' HB2' ' HB ' ' A' ' 2' ' ' ILE . 9.5 m -117.04 159.52 40.74 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.775 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -79.05 145.7 19.68 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.34 2.027 . . . . 0.0 111.992 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -61.53 109.59 1.22 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.872 0.368 . . . . 0.0 110.844 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 130.12 14.64 1.99 Allowed Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.635 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.1 p -139.11 154.07 48.09 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.749 0.309 . . . . 0.0 111.156 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.1 t -104.27 153.06 21.46 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.177 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.2 m -73.61 114.01 11.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.055 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.432 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 0.4 OUTLIER -120.87 129.99 53.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.596 179.773 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.4 mt -94.46 140.01 30.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.888 0.375 . . . . 0.0 111.181 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.562 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 0.1 OUTLIER -86.77 162.03 45.82 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.532 179.805 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.31 -8.06 6.12 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.458 2.105 . . . . 0.0 112.714 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -118.05 23.68 11.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.824 0.345 . . . . 0.0 111.094 -179.655 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.28 46.77 85.66 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.673 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.562 ' HB ' ' HB2' ' A' ' 19' ' ' SER . 60.6 t -113.82 117.73 56.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.805 0.336 . . . . 0.0 110.74 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 87.5 m95 -77.78 117.06 18.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.35 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.432 ' CE2' ' HB3' ' A' ' 17' ' ' SER . 53.8 p90 -137.98 147.22 44.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.501 179.241 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -85.31 122.81 30.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.096 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 24.9 t -116.03 125.5 28.55 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.033 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -71.93 152.0 57.13 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.482 2.121 . . . . 0.0 112.324 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -108.1 -30.43 8.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.856 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 11.7 t . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.26 -0.876 . . . . 0.0 110.933 179.92 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.408 ' HB ' ' H ' ' A' ' 2' ' ' ILE . 1.8 m . . . . . 0 N--CA 1.486 1.329 0 CA-C-O 120.751 0.31 . . . . 0.0 111.119 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.658 HD11 ' HA ' ' A' ' 12' ' ' ASP . 6.1 mm -121.09 135.65 60.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.1 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 70.8 m-70 -138.42 87.48 2.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.794 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 12.0 m -79.15 -53.37 7.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.985 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -114.68 11.35 16.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.116 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 56.01 23.57 6.88 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.335 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -115.79 -56.6 2.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.077 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 87.4 m -105.68 100.32 9.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.023 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.407 ' H ' HG13 ' A' ' 9' ' ' ILE . 6.3 mt -68.83 128.63 32.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.728 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.2 m -119.59 150.36 49.9 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.207 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -59.18 147.8 88.89 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.631 2.221 . . . . 0.0 112.358 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.658 ' HA ' HD11 ' A' ' 2' ' ' ILE . 7.2 p-10 -58.66 -25.35 62.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.406 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -88.49 21.28 26.37 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.694 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.1 p -146.14 177.6 8.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.843 0.354 . . . . 0.0 111.194 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.443 HG22 ' O ' ' A' ' 27' ' ' SER . 6.7 t -132.57 159.96 37.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.02 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -84.16 105.33 14.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.1 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -118.35 139.65 51.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.491 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.424 HD23 ' HA ' ' A' ' 18' ' ' LEU . 8.4 mt -92.85 143.96 25.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.03 0.443 . . . . 0.0 111.328 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.7 164.04 18.34 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.403 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_exo -58.36 -4.8 1.88 Allowed 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.491 2.127 . . . . 0.0 112.812 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -117.61 21.53 12.92 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.799 0.333 . . . . 0.0 110.91 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 62.91 44.36 97.54 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.534 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 54.2 t -113.0 132.55 61.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.755 0.312 . . . . 0.0 110.866 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 82.7 m95 -91.06 104.84 17.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.219 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 55.1 p90 -118.3 152.74 35.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.557 179.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.433 ' HA ' ' O ' ' A' ' 15' ' ' THR . 1.8 m -91.86 117.06 29.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.026 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.443 ' O ' HG22 ' A' ' 15' ' ' THR . 0.1 OUTLIER -105.47 132.58 20.76 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.726 179.911 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -74.14 140.42 28.02 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.339 2.026 . . . . 0.0 112.515 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -139.39 178.28 7.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.905 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 23.0 t . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.188 -0.911 . . . . 0.0 110.851 179.949 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 26.9 m . . . . . 0 N--CA 1.485 1.315 0 CA-C-O 120.789 0.328 . . . . 0.0 111.062 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.571 ' HB ' ' HB2' ' A' ' 10' ' ' CYS . 12.6 mm -121.48 119.75 59.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.245 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -126.62 85.17 2.35 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.72 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.2 m -72.26 -58.84 3.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.997 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -115.82 32.55 6.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.063 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 58.4 15.76 3.69 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.205 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -136.58 155.62 49.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.74 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 72.3 m 53.37 86.75 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.91 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 18.8 mt -71.21 130.6 35.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.092 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.571 ' HB2' ' HB ' ' A' ' 2' ' ' ILE . 13.0 m -112.29 155.08 44.13 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.809 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -64.41 139.97 67.59 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.516 2.144 . . . . 0.0 112.162 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -59.65 104.27 0.27 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.863 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 138.65 -12.12 3.44 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.473 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.445 ' OG1' ' HB3' ' A' ' 26' ' ' CYS . 47.5 p -108.04 161.52 14.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.763 0.316 . . . . 0.0 111.121 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.469 HG22 ' O ' ' A' ' 27' ' ' SER . 6.4 t -111.28 144.87 39.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.089 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -76.33 114.25 14.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.874 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.7 t -122.1 139.96 53.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.849 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.441 HD23 ' HA ' ' A' ' 18' ' ' LEU . 6.5 mt -95.06 125.73 39.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.899 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.25 159.91 81.2 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.774 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -54.04 -12.04 3.19 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.792 2.328 . . . . 0.0 112.851 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -105.19 -27.2 11.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.969 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 117.27 52.95 0.32 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.516 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 23.3 t -124.7 129.57 73.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.766 0.317 . . . . 0.0 111.042 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 92.7 m95 -82.78 99.24 9.56 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.04 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -116.36 151.7 35.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.727 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.445 ' HB3' ' OG1' ' A' ' 14' ' ' THR . 0.2 OUTLIER -89.18 127.36 35.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.247 -179.638 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.469 ' O ' HG22 ' A' ' 15' ' ' THR . 0.4 OUTLIER -118.49 114.21 36.31 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.717 179.778 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -66.55 130.64 24.08 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.411 2.074 . . . . 0.0 112.194 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 12.7 p90 -113.11 178.15 4.38 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.849 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.177 -0.916 . . . . 0.0 110.874 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 17.1 m . . . . . 0 N--CA 1.485 1.308 0 CA-C-O 120.775 0.322 . . . . 0.0 111.175 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.586 HD11 ' HA ' ' A' ' 12' ' ' ASP . 3.3 mm -101.3 145.22 11.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.114 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 26.1 m-70 -133.9 -33.6 1.04 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.915 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.446 ' HB2' ' H ' ' A' ' 5' ' ' ASP . 0.4 OUTLIER 55.51 -94.05 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.164 179.894 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.446 ' H ' ' HB2' ' A' ' 4' ' ' CYS . 0.9 OUTLIER -94.37 30.71 1.89 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.8 0.333 . . . . 0.0 110.666 179.881 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 60.91 14.49 5.28 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.068 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -134.85 153.31 52.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.818 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 90.2 m 55.64 87.29 0.05 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.864 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 8.0 mt -69.28 146.88 12.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.151 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 7.0 m -138.74 157.58 71.64 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.832 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -62.97 145.74 94.5 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.485 2.123 . . . . 0.0 112.085 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.586 ' HA ' HD11 ' A' ' 2' ' ' ILE . 3.3 p-10 -60.76 -21.3 62.88 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.11 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -85.3 14.15 51.66 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.663 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.449 ' OG1' ' HB3' ' A' ' 26' ' ' CYS . 66.5 p -140.47 171.08 14.63 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.819 0.343 . . . . 0.0 111.187 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.48 HG22 ' O ' ' A' ' 27' ' ' SER . 8.9 t -126.71 162.53 25.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.109 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -74.98 120.76 20.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.969 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -128.19 131.98 48.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.586 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.438 HD23 ' HA ' ' A' ' 18' ' ' LEU . 6.1 mt -91.84 124.98 36.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.886 0.374 . . . . 0.0 111.135 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.49 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 0.1 OUTLIER -78.95 162.38 64.98 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.522 179.702 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -56.12 -11.41 5.77 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.487 2.124 . . . . 0.0 112.616 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -113.76 26.2 10.56 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.072 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 59.01 59.07 11.44 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.587 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.49 ' HB ' ' HB2' ' A' ' 19' ' ' SER . 41.0 t -126.64 120.52 56.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.824 0.345 . . . . 0.0 111.282 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 94.7 m95 -81.25 99.62 8.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.902 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 56.0 p90 -117.82 161.75 19.22 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.926 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.449 ' HB3' ' OG1' ' A' ' 14' ' ' THR . 0.0 OUTLIER -87.07 129.0 35.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.092 -179.768 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.48 ' O ' HG22 ' A' ' 15' ' ' THR . 0.1 OUTLIER -130.11 117.15 17.97 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.895 -179.991 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -61.74 144.77 97.44 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.494 2.129 . . . . 0.0 112.215 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -113.0 157.81 21.05 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.869 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.363 -0.827 . . . . 0.0 110.985 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 2.9 m . . . . . 0 N--CA 1.485 1.316 0 CA-C-O 120.832 0.348 . . . . 0.0 111.148 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.513 HD11 ' HA ' ' A' ' 12' ' ' ASP . 3.0 mm -103.48 159.08 4.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.907 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 17.2 m-70 -137.25 -64.21 0.57 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.913 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 15.2 m 60.93 -86.4 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.194 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -74.73 -4.93 40.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.918 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 56.89 22.83 7.5 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.41 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -134.5 -21.46 1.76 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.024 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 42.8 m -130.46 94.26 3.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.972 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 10.8 mt -64.14 132.58 30.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.895 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.446 ' O ' HG12 ' A' ' 2' ' ' ILE . 6.4 m -120.27 153.33 55.72 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.164 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -56.59 142.88 90.2 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.603 2.202 . . . . 0.0 112.335 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.513 ' HA ' HD11 ' A' ' 2' ' ' ILE . 21.2 t0 -57.58 -24.28 55.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.379 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -92.69 21.47 38.74 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.884 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 82.2 p -141.28 173.77 11.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.902 0.382 . . . . 0.0 111.245 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.5 t -130.66 155.42 46.61 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.92 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -73.47 120.39 19.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.93 0.395 . . . . 0.0 110.986 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.6 t -132.18 135.92 46.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.52 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.1 mt -99.99 132.59 45.26 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.922 0.391 . . . . 0.0 111.073 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 6.1 p -77.61 163.1 65.75 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.794 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.45 -6.43 4.17 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.592 2.195 . . . . 0.0 112.68 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -117.1 20.57 13.7 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.813 0.339 . . . . 0.0 111.096 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.52 47.58 76.69 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.903 -0.665 . . . . 0.0 113.009 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 51.8 t -117.6 117.15 54.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.765 0.317 . . . . 0.0 110.755 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -71.32 124.49 24.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.322 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 46.8 p90 -147.65 147.12 29.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.364 179.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -91.02 124.34 35.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.932 0.396 . . . . 0.0 111.275 -179.571 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 11.0 t -108.39 127.72 26.98 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.423 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -76.08 126.62 9.4 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.316 2.011 . . . . 0.0 112.445 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -101.07 -15.84 17.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.816 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 9.6 p . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.251 -0.881 . . . . 0.0 110.959 -179.909 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 6.1 m . . . . . 0 N--CA 1.485 1.315 0 CA-C-O 120.811 0.339 . . . . 0.0 111.024 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.68 ' HB ' ' HB2' ' A' ' 10' ' ' CYS . 4.7 mm -120.15 104.1 15.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.043 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 -95.49 74.96 3.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.919 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.421 ' HB2' ' HB ' ' A' ' 8' ' ' THR . 4.1 m -62.73 113.06 2.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.85 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 59.98 18.19 7.35 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.088 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 55.69 26.26 9.14 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.381 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -137.95 -2.07 1.93 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.253 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.421 ' HB ' ' HB2' ' A' ' 4' ' ' CYS . 21.7 m -143.28 108.3 4.95 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.285 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 5.8 mt -84.44 143.32 11.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.869 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.68 ' HB2' ' HB ' ' A' ' 2' ' ' ILE . 12.3 m -145.8 154.62 51.8 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.203 -179.568 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -57.86 143.5 95.63 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.536 2.158 . . . . 0.0 112.21 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -54.83 -31.77 59.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.282 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -85.15 23.33 8.21 Favored Glycine 0 CA--C 1.518 0.276 0 C-N-CA 120.892 -0.67 . . . . 0.0 113.253 -179.495 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 81.6 p -142.61 165.07 28.4 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.835 0.35 . . . . 0.0 111.259 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.448 HG22 ' O ' ' A' ' 27' ' ' SER . 8.2 t -124.69 164.1 20.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.018 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 3.6 m -80.47 118.76 22.36 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.259 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.9 m -125.49 140.66 52.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.365 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.439 HD23 ' HA ' ' A' ' 18' ' ' LEU . 7.0 mt -94.28 131.92 39.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.011 0.434 . . . . 0.0 111.467 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.63 163.83 34.26 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.411 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -56.62 -8.36 2.84 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.549 2.166 . . . . 0.0 112.665 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -115.82 25.84 10.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.024 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 58.91 35.43 82.99 Favored Glycine 0 C--N 1.33 0.201 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.684 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 59.3 t -105.45 124.9 60.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.872 0.368 . . . . 0.0 111.039 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 80.9 m95 -82.29 112.33 19.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.205 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 49.3 p90 -125.18 154.0 42.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.682 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -86.44 129.12 34.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.923 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.448 ' O ' HG22 ' A' ' 15' ' ' THR . 28.1 t -130.96 125.33 21.17 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.03 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 27' ' ' SER . 16.3 Cg_exo -68.35 149.35 75.25 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.753 2.302 . . . . 0.0 112.204 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -104.99 -19.37 13.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.93 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 29.0 t . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.213 -0.899 . . . . 0.0 111.107 -179.959 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 3.9 m . . . . . 0 N--CA 1.485 1.314 0 CA-C-O 120.835 0.35 . . . . 0.0 111.172 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.819 ' HB ' ' HB2' ' A' ' 10' ' ' CYS . 5.2 mm -92.27 129.27 43.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.245 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 16.8 m-70 -121.61 -44.13 2.35 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.088 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.566 ' SG ' HG22 ' A' ' 2' ' ' ILE . 0.7 OUTLIER 58.8 -90.84 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.5 179.875 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.48 ' H ' ' HB2' ' A' ' 4' ' ' CYS . 0.8 OUTLIER -79.61 2.51 22.15 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.088 -179.649 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 58.23 16.76 4.17 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.364 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -100.98 -36.24 9.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.85 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 14.8 t -125.33 159.67 31.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.915 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 44.0 mt -111.1 142.59 23.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.93 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.819 ' HB2' ' HB ' ' A' ' 2' ' ' ILE . 56.4 m -134.43 157.22 77.89 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.905 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -76.38 141.33 22.69 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.308 2.006 . . . . 0.0 112.167 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -55.43 99.96 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.116 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 140.59 -4.79 2.53 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.471 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.421 ' O ' HG13 ' A' ' 2' ' ' ILE . 12.2 p -113.12 151.31 30.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.726 0.298 . . . . 0.0 110.867 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.2 t -105.21 152.73 22.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.281 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -76.21 112.49 12.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.646 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -120.69 141.74 50.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.078 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.551 HD22 ' HA2' ' A' ' 22' ' ' GLY . 6.6 mt -97.65 125.79 42.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.799 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.44 ' HB3' ' HB ' ' A' ' 23' ' ' VAL . 0.3 OUTLIER -77.6 164.06 60.11 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.785 -179.89 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.466 ' HG2' ' CZ ' ' A' ' 21' ' ' TYR . 9.5 Cg_endo -54.6 -12.08 3.97 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 122.742 2.295 . . . . 0.0 112.691 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.466 ' CZ ' ' HG2' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -117.57 30.11 7.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.035 -179.518 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.551 ' HA2' HD22 ' A' ' 18' ' ' LEU . . . 56.8 48.81 75.25 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.568 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.44 ' HB ' ' HB3' ' A' ' 19' ' ' SER . 16.2 t -113.46 117.15 54.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.795 0.331 . . . . 0.0 111.066 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -76.07 105.06 6.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.209 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -123.47 156.48 35.49 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.834 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 1.6 m -87.95 108.28 19.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.224 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -94.55 117.38 66.99 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.632 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.35 127.33 13.22 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.467 2.111 . . . . 0.0 112.484 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -119.21 -21.63 7.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.006 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.877 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 16.0 m . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.822 0.344 . . . . 0.0 111.145 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 13.3 mm -84.35 116.74 28.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.104 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -94.17 -48.76 6.06 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.025 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 63.54 -84.35 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.207 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.438 ' OD2' ' HB3' ' A' ' 7' ' ' ALA . 20.0 p-10 -86.33 9.62 17.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.151 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 55.09 29.38 12.39 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.237 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.438 ' HB3' ' OD2' ' A' ' 5' ' ' ASP . . . -137.27 -31.46 0.81 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.244 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.4 m -112.26 118.55 35.59 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.271 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.6 mp -88.69 142.16 13.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.845 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.408 ' HB3' ' OG1' ' A' ' 14' ' ' THR . 20.5 m -105.37 152.63 39.93 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.395 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.48 ' O ' ' HB2' ' A' ' 12' ' ' ASP . 10.8 Cg_exo -73.38 18.69 0.39 Allowed 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 123.09 2.526 . . . . 0.0 112.958 -179.615 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.48 ' HB2' ' O ' ' A' ' 11' ' ' PRO . 21.5 m-20 69.65 138.14 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.034 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 78.18 22.41 68.25 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.194 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.497 ' OG1' ' HB3' ' A' ' 26' ' ' CYS . 70.5 p -129.26 175.02 9.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.83 0.348 . . . . 0.0 111.185 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.546 HG22 ' O ' ' A' ' 27' ' ' SER . 9.9 t -128.79 152.95 47.9 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.01 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.7 m -72.7 112.5 8.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.164 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -127.75 136.93 52.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.657 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.2 mt -91.57 150.22 21.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.076 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.1 p -94.05 161.35 30.02 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.791 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -55.73 -13.91 9.38 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.553 2.169 . . . . 0.0 112.511 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -102.93 -22.03 13.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.848 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 113.29 28.64 3.24 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.633 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 48.5 t -96.96 140.02 18.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.803 0.335 . . . . 0.0 110.947 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 67.3 m95 -93.08 103.42 15.72 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.261 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 55.3 p90 -119.66 168.32 11.16 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.318 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.497 ' HB3' ' OG1' ' A' ' 14' ' ' THR . 15.6 m -107.85 138.13 44.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.927 0.394 . . . . 0.0 111.441 -179.498 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.546 ' O ' HG22 ' A' ' 15' ' ' THR . 4.8 m -125.73 118.72 24.29 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.697 179.703 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.493 ' HA ' ' HA ' ' A' ' 14' ' ' THR . 19.9 Cg_exo -65.49 135.3 41.88 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.577 2.184 . . . . 0.0 112.321 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 28.1 p90 -118.82 167.72 11.44 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.049 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.179 -0.915 . . . . 0.0 111.073 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 13.6 m . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.796 0.331 . . . . 0.0 111.105 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 12.2 mm -78.33 137.2 22.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.239 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 2.7 m80 -120.83 -47.46 2.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.847 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 60.94 -87.1 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.38 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.66 -0.0 19.17 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.004 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 59.71 23.14 11.97 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.005 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -120.55 -45.12 2.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.932 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.3 t -104.31 152.47 22.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.933 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 17.9 mt -111.52 136.4 47.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.808 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 16.9 m -137.24 162.13 57.1 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.006 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.405 ' HG2' ' OG1' ' A' ' 14' ' ' THR . 36.8 Cg_endo -66.38 147.18 82.5 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.128 1.886 . . . . 0.0 111.934 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -64.07 -7.72 9.62 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.411 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -104.62 27.51 18.74 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.839 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.405 ' OG1' ' HG2' ' A' ' 11' ' ' PRO . 36.7 p -142.78 173.94 11.1 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.896 0.379 . . . . 0.0 111.258 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 10.0 t -126.33 160.11 31.3 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.025 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -74.04 111.53 9.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.715 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -116.68 136.19 53.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.03 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.557 HD22 ' HA2' ' A' ' 22' ' ' GLY . 5.8 mt -98.37 125.3 43.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.935 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.698 ' HB3' ' HB ' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -80.93 163.96 53.12 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.741 179.995 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.465 ' HG2' ' CE1' ' A' ' 21' ' ' TYR . 9.3 Cg_endo -54.12 -12.38 3.62 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.787 2.325 . . . . 0.0 112.692 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.465 ' CE1' ' HG2' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -116.78 32.47 6.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.927 -179.594 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.557 ' HA2' HD22 ' A' ' 18' ' ' LEU . . . 54.53 55.3 27.76 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.568 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.698 ' HB ' ' HB3' ' A' ' 19' ' ' SER . 40.7 t -116.02 123.84 71.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.824 0.345 . . . . 0.0 111.345 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 97.0 m95 -85.41 93.18 8.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.76 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -113.66 162.23 16.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.048 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -85.28 119.49 25.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.11 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.433 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 4.8 t -111.19 116.19 51.59 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.904 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 27' ' ' SER . 7.4 Cg_exo -73.08 128.32 12.95 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.833 2.355 . . . . 0.0 112.275 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -101.31 -0.28 35.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.028 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.5 m . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.928 179.993 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 13.4 m . . . . . 0 N--CA 1.485 1.31 0 CA-C-O 120.765 0.317 . . . . 0.0 111.155 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.778 ' HB ' ' HB2' ' A' ' 10' ' ' CYS . 3.8 mp -117.3 113.49 42.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.977 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 25.0 m-70 -102.62 -45.37 5.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.806 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 58.81 -90.13 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.218 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -79.84 4.09 17.63 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.946 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 56.77 27.48 12.84 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.96 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -129.49 -14.14 4.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.104 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.25 123.96 14.15 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.192 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 7.5 mt -86.58 154.99 3.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.992 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.778 ' HB2' ' HB ' ' A' ' 2' ' ' ILE . 22.9 m -144.68 153.14 54.26 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.065 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -63.56 141.39 79.95 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.424 2.083 . . . . 0.0 112.022 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -59.52 104.13 0.25 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.684 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 134.1 0.49 3.82 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.466 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.414 ' O ' HG12 ' A' ' 2' ' ' ILE . 43.6 p -116.97 153.96 31.71 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.822 0.344 . . . . 0.0 111.179 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.424 HG22 ' O ' ' A' ' 27' ' ' SER . 10.1 t -105.31 156.06 18.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.142 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -82.18 113.14 19.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.663 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.1 m -124.65 132.7 53.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.9 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.414 HD23 ' HA ' ' A' ' 18' ' ' LEU . 5.2 mt -89.02 136.47 33.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.022 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -83.15 160.42 60.16 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.513 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -58.07 -11.95 11.45 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.464 2.109 . . . . 0.0 112.529 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.6 24.01 12.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.779 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 62.8 52.64 46.86 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 121.045 -0.598 . . . . 0.0 112.647 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.7 t -124.02 114.76 42.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.726 0.298 . . . . 0.0 110.766 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -72.78 121.09 19.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.064 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 54.9 p90 -137.65 153.68 49.82 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.888 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -90.03 125.64 35.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.093 -179.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.424 ' O ' HG22 ' A' ' 15' ' ' THR . 3.2 t -114.98 118.98 39.83 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.783 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.14 139.73 56.73 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.398 2.065 . . . . 0.0 112.465 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 42.9 p90 . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.889 179.921 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 1.6 m . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.753 0.311 . . . . 0.0 111.08 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.729 ' HB ' ' HB2' ' A' ' 10' ' ' CYS . 7.5 mm -109.07 121.69 62.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.507 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 10.3 m170 -121.26 119.92 33.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.273 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.2 m -120.29 -18.21 8.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.654 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -146.72 7.85 0.97 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.641 0.258 . . . . 0.0 111.248 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 55.91 21.46 4.91 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.214 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -124.03 -51.76 1.78 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.961 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.2 m -105.45 92.44 4.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.965 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 22.4 mt -67.92 137.06 25.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.22 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.729 ' HB2' ' HB ' ' A' ' 2' ' ' ILE . 9.5 m -117.04 159.52 40.74 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.775 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -79.05 145.7 19.68 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.34 2.027 . . . . 0.0 111.992 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -61.53 109.59 1.22 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.872 0.368 . . . . 0.0 110.844 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 130.12 14.64 1.99 Allowed Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.635 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.1 p -139.11 154.07 48.09 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.749 0.309 . . . . 0.0 111.156 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.1 t -104.27 153.06 21.46 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.177 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.2 m -73.61 114.01 11.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.055 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.432 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 0.4 OUTLIER -120.87 129.99 53.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.596 179.773 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.4 mt -94.46 140.01 30.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.888 0.375 . . . . 0.0 111.181 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.562 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 0.1 OUTLIER -86.77 162.03 45.82 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.532 179.805 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.31 -8.06 6.12 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.458 2.105 . . . . 0.0 112.714 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -118.05 23.68 11.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.824 0.345 . . . . 0.0 111.094 -179.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.28 46.77 85.66 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.673 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.562 ' HB ' ' HB2' ' A' ' 19' ' ' SER . 60.6 t -113.82 117.73 56.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.805 0.336 . . . . 0.0 110.74 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 87.5 m95 -77.78 117.06 18.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.35 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.432 ' CE2' ' HB3' ' A' ' 17' ' ' SER . 53.8 p90 -137.98 147.22 44.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.501 179.241 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -85.31 122.81 30.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.096 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 24.9 t -116.03 125.5 28.55 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.033 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -71.93 152.0 57.13 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.482 2.121 . . . . 0.0 112.324 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.856 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . 0.408 ' HB ' ' H ' ' A' ' 2' ' ' ILE . 1.8 m . . . . . 0 N--CA 1.486 1.329 0 CA-C-O 120.751 0.31 . . . . 0.0 111.119 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.658 HD11 ' HA ' ' A' ' 12' ' ' ASP . 6.1 mm -121.09 135.65 60.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.1 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 70.8 m-70 -138.42 87.48 2.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.794 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 12.0 m -79.15 -53.37 7.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.985 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -114.68 11.35 16.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.116 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 56.01 23.57 6.88 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.335 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -115.79 -56.6 2.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.077 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 87.4 m -105.68 100.32 9.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.023 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.407 ' H ' HG13 ' A' ' 9' ' ' ILE . 6.3 mt -68.83 128.63 32.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.728 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.2 m -119.59 150.36 49.9 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.207 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -59.18 147.8 88.89 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.631 2.221 . . . . 0.0 112.358 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.658 ' HA ' HD11 ' A' ' 2' ' ' ILE . 7.2 p-10 -58.66 -25.35 62.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.406 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -88.49 21.28 26.37 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.694 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.1 p -146.14 177.6 8.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.843 0.354 . . . . 0.0 111.194 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.443 HG22 ' O ' ' A' ' 27' ' ' SER . 6.7 t -132.57 159.96 37.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.02 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -84.16 105.33 14.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.1 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -118.35 139.65 51.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.491 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.424 HD23 ' HA ' ' A' ' 18' ' ' LEU . 8.4 mt -92.85 143.96 25.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.03 0.443 . . . . 0.0 111.328 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.7 164.04 18.34 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.403 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_exo -58.36 -4.8 1.88 Allowed 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.491 2.127 . . . . 0.0 112.812 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -117.61 21.53 12.92 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.799 0.333 . . . . 0.0 110.91 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 62.91 44.36 97.54 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.534 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 54.2 t -113.0 132.55 61.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.755 0.312 . . . . 0.0 110.866 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 82.7 m95 -91.06 104.84 17.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.219 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 55.1 p90 -118.3 152.74 35.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.557 179.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.433 ' HA ' ' O ' ' A' ' 15' ' ' THR . 1.8 m -91.86 117.06 29.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.026 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.443 ' O ' HG22 ' A' ' 15' ' ' THR . 0.1 OUTLIER -105.47 132.58 20.76 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.726 179.911 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -74.14 140.42 28.02 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.339 2.026 . . . . 0.0 112.515 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 55.4 p90 . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.905 179.771 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 26.9 m . . . . . 0 N--CA 1.485 1.315 0 CA-C-O 120.789 0.328 . . . . 0.0 111.062 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.571 ' HB ' ' HB2' ' A' ' 10' ' ' CYS . 12.6 mm -121.48 119.75 59.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.245 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -126.62 85.17 2.35 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.72 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.2 m -72.26 -58.84 3.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.997 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -115.82 32.55 6.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.063 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 58.4 15.76 3.69 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.205 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -136.58 155.62 49.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.74 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 72.3 m 53.37 86.75 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.91 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 18.8 mt -71.21 130.6 35.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.092 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.571 ' HB2' ' HB ' ' A' ' 2' ' ' ILE . 13.0 m -112.29 155.08 44.13 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.809 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -64.41 139.97 67.59 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.516 2.144 . . . . 0.0 112.162 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -59.65 104.27 0.27 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.863 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 138.65 -12.12 3.44 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.473 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.445 ' OG1' ' HB3' ' A' ' 26' ' ' CYS . 47.5 p -108.04 161.52 14.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.763 0.316 . . . . 0.0 111.121 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.469 HG22 ' O ' ' A' ' 27' ' ' SER . 6.4 t -111.28 144.87 39.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.089 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -76.33 114.25 14.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.874 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.7 t -122.1 139.96 53.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.849 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.441 ' HA ' HD23 ' A' ' 18' ' ' LEU . 6.5 mt -95.06 125.73 39.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.899 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.25 159.91 81.2 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.774 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -54.04 -12.04 3.19 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.792 2.328 . . . . 0.0 112.851 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -105.19 -27.2 11.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.969 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 117.27 52.95 0.32 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.516 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 23.3 t -124.7 129.57 73.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.766 0.317 . . . . 0.0 111.042 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 92.7 m95 -82.78 99.24 9.56 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.04 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -116.36 151.7 35.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.727 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.445 ' HB3' ' OG1' ' A' ' 14' ' ' THR . 0.2 OUTLIER -89.18 127.36 35.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.247 -179.638 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.469 ' O ' HG22 ' A' ' 15' ' ' THR . 0.4 OUTLIER -118.49 114.21 36.31 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.717 179.778 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -66.55 130.64 24.08 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.411 2.074 . . . . 0.0 112.194 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 12.7 p90 . . . . . 0 C--N 1.328 -0.365 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.849 179.799 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 17.1 m . . . . . 0 N--CA 1.485 1.308 0 CA-C-O 120.775 0.322 . . . . 0.0 111.175 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.586 HD11 ' HA ' ' A' ' 12' ' ' ASP . 3.3 mm -101.3 145.22 11.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.114 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 26.1 m-70 -133.9 -33.6 1.04 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.915 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.446 ' HB2' ' H ' ' A' ' 5' ' ' ASP . 0.4 OUTLIER 55.51 -94.05 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.164 179.894 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.446 ' H ' ' HB2' ' A' ' 4' ' ' CYS . 0.9 OUTLIER -94.37 30.71 1.89 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.8 0.333 . . . . 0.0 110.666 179.881 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 60.91 14.49 5.28 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.068 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -134.85 153.31 52.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.818 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 90.2 m 55.64 87.29 0.05 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.864 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 8.0 mt -69.28 146.88 12.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.151 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 7.0 m -138.74 157.58 71.64 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.832 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -62.97 145.74 94.5 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.485 2.123 . . . . 0.0 112.085 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.586 ' HA ' HD11 ' A' ' 2' ' ' ILE . 3.3 p-10 -60.76 -21.3 62.88 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.11 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -85.3 14.15 51.66 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.663 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.449 ' OG1' ' HB3' ' A' ' 26' ' ' CYS . 66.5 p -140.47 171.08 14.63 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.819 0.343 . . . . 0.0 111.187 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.48 HG22 ' O ' ' A' ' 27' ' ' SER . 8.9 t -126.71 162.53 25.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.109 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -74.98 120.76 20.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.969 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -128.19 131.98 48.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.586 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.438 HD23 ' HA ' ' A' ' 18' ' ' LEU . 6.1 mt -91.84 124.98 36.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.886 0.374 . . . . 0.0 111.135 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.49 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 0.1 OUTLIER -78.95 162.38 64.98 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.522 179.702 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -56.12 -11.41 5.77 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.487 2.124 . . . . 0.0 112.616 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -113.76 26.2 10.56 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.072 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 59.01 59.07 11.44 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.587 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.49 ' HB ' ' HB2' ' A' ' 19' ' ' SER . 41.0 t -126.64 120.52 56.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.824 0.345 . . . . 0.0 111.282 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 94.7 m95 -81.25 99.62 8.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.902 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 56.0 p90 -117.82 161.75 19.22 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.926 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.449 ' HB3' ' OG1' ' A' ' 14' ' ' THR . 0.0 OUTLIER -87.07 129.0 35.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.092 -179.768 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.48 ' O ' HG22 ' A' ' 15' ' ' THR . 0.1 OUTLIER -130.11 117.15 17.97 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.895 -179.991 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -61.74 144.77 97.44 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.494 2.129 . . . . 0.0 112.215 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.33 -0.24 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.869 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 2.9 m . . . . . 0 N--CA 1.485 1.316 0 CA-C-O 120.832 0.348 . . . . 0.0 111.148 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.513 HD11 ' HA ' ' A' ' 12' ' ' ASP . 3.0 mm -103.48 159.08 4.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.907 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 17.2 m-70 -137.25 -64.21 0.57 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.913 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 15.2 m 60.93 -86.4 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.194 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -74.73 -4.93 40.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.918 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 56.89 22.83 7.5 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.41 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -134.5 -21.46 1.76 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.024 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 42.8 m -130.46 94.26 3.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.972 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 10.8 mt -64.14 132.58 30.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.895 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.446 ' O ' HG12 ' A' ' 2' ' ' ILE . 6.4 m -120.27 153.33 55.72 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.164 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -56.59 142.88 90.2 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.603 2.202 . . . . 0.0 112.335 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.513 ' HA ' HD11 ' A' ' 2' ' ' ILE . 21.2 t0 -57.58 -24.28 55.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.379 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -92.69 21.47 38.74 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.884 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 82.2 p -141.28 173.77 11.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.902 0.382 . . . . 0.0 111.245 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.5 t -130.66 155.42 46.61 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.92 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -73.47 120.39 19.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.93 0.395 . . . . 0.0 110.986 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.6 t -132.18 135.92 46.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.52 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.1 mt -99.99 132.59 45.26 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.922 0.391 . . . . 0.0 111.073 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 6.1 p -77.61 163.1 65.75 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.794 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.45 -6.43 4.17 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.592 2.195 . . . . 0.0 112.68 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -117.1 20.57 13.7 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.813 0.339 . . . . 0.0 111.096 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.52 47.58 76.69 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.903 -0.665 . . . . 0.0 113.009 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 51.8 t -117.6 117.15 54.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.765 0.317 . . . . 0.0 110.755 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -71.32 124.49 24.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.322 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 46.8 p90 -147.65 147.12 29.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.364 179.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -91.02 124.34 35.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.932 0.396 . . . . 0.0 111.275 -179.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 11.0 t -108.39 127.72 26.98 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.423 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -76.08 126.62 9.4 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.316 2.011 . . . . 0.0 112.445 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.816 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 6.1 m . . . . . 0 N--CA 1.485 1.315 0 CA-C-O 120.811 0.339 . . . . 0.0 111.024 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.68 ' HB ' ' HB2' ' A' ' 10' ' ' CYS . 4.7 mm -120.15 104.1 15.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.043 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 -95.49 74.96 3.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.919 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.421 ' HB2' ' HB ' ' A' ' 8' ' ' THR . 4.1 m -62.73 113.06 2.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.85 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 59.98 18.19 7.35 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.088 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 55.69 26.26 9.14 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.381 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -137.95 -2.07 1.93 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.253 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.421 ' HB ' ' HB2' ' A' ' 4' ' ' CYS . 21.7 m -143.28 108.3 4.95 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.285 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 5.8 mt -84.44 143.32 11.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.869 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.68 ' HB2' ' HB ' ' A' ' 2' ' ' ILE . 12.3 m -145.8 154.62 51.8 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.203 -179.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -57.86 143.5 95.63 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.536 2.158 . . . . 0.0 112.21 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -54.83 -31.77 59.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.282 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -85.15 23.33 8.21 Favored Glycine 0 CA--C 1.518 0.276 0 C-N-CA 120.892 -0.67 . . . . 0.0 113.253 -179.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 81.6 p -142.61 165.07 28.4 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.835 0.35 . . . . 0.0 111.259 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.448 HG22 ' O ' ' A' ' 27' ' ' SER . 8.2 t -124.69 164.1 20.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.018 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 3.6 m -80.47 118.76 22.36 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.259 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.9 m -125.49 140.66 52.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.365 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.439 HD23 ' HA ' ' A' ' 18' ' ' LEU . 7.0 mt -94.28 131.92 39.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.011 0.434 . . . . 0.0 111.467 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.63 163.83 34.26 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.411 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -56.62 -8.36 2.84 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.549 2.166 . . . . 0.0 112.665 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -115.82 25.84 10.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.024 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 58.91 35.43 82.99 Favored Glycine 0 C--N 1.33 0.201 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.684 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 59.3 t -105.45 124.9 60.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.872 0.368 . . . . 0.0 111.039 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 80.9 m95 -82.29 112.33 19.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.205 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 49.3 p90 -125.18 154.0 42.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.682 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -86.44 129.12 34.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.923 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.448 ' O ' HG22 ' A' ' 15' ' ' THR . 28.1 t -130.96 125.33 21.17 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.03 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 27' ' ' SER . 16.3 Cg_exo -68.35 149.35 75.25 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.753 2.302 . . . . 0.0 112.204 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.93 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 3.9 m . . . . . 0 N--CA 1.485 1.314 0 CA-C-O 120.835 0.35 . . . . 0.0 111.172 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.819 ' HB ' ' HB2' ' A' ' 10' ' ' CYS . 5.2 mm -92.27 129.27 43.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.245 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 16.8 m-70 -121.61 -44.13 2.35 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.088 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.566 ' SG ' HG22 ' A' ' 2' ' ' ILE . 0.7 OUTLIER 58.8 -90.84 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.5 179.875 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.48 ' H ' ' HB2' ' A' ' 4' ' ' CYS . 0.8 OUTLIER -79.61 2.51 22.15 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.088 -179.649 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 58.23 16.76 4.17 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.364 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -100.98 -36.24 9.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.85 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 14.8 t -125.33 159.67 31.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.915 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 44.0 mt -111.1 142.59 23.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.93 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.819 ' HB2' ' HB ' ' A' ' 2' ' ' ILE . 56.4 m -134.43 157.22 77.89 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.905 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -76.38 141.33 22.69 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.308 2.006 . . . . 0.0 112.167 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -55.43 99.96 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.116 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 140.59 -4.79 2.53 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.471 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.421 ' O ' HG13 ' A' ' 2' ' ' ILE . 12.2 p -113.12 151.31 30.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.726 0.298 . . . . 0.0 110.867 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.2 t -105.21 152.73 22.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.281 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -76.21 112.49 12.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.646 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -120.69 141.74 50.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.078 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.551 HD22 ' HA2' ' A' ' 22' ' ' GLY . 6.6 mt -97.65 125.79 42.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.799 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.44 ' HB3' ' HB ' ' A' ' 23' ' ' VAL . 0.3 OUTLIER -77.6 164.06 60.11 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.785 -179.89 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.466 ' HG2' ' CZ ' ' A' ' 21' ' ' TYR . 9.5 Cg_endo -54.6 -12.08 3.97 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 122.742 2.295 . . . . 0.0 112.691 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.466 ' CZ ' ' HG2' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -117.57 30.11 7.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.035 -179.518 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.551 ' HA2' HD22 ' A' ' 18' ' ' LEU . . . 56.8 48.81 75.25 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.568 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.44 ' HB ' ' HB3' ' A' ' 19' ' ' SER . 16.2 t -113.46 117.15 54.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.795 0.331 . . . . 0.0 111.066 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -76.07 105.06 6.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.209 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -123.47 156.48 35.49 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.834 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 1.6 m -87.95 108.28 19.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.224 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -94.55 117.38 66.99 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.632 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.35 127.33 13.22 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.467 2.111 . . . . 0.0 112.484 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 50.0 p90 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.006 179.952 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 16.0 m . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.822 0.344 . . . . 0.0 111.145 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 13.3 mm -84.35 116.74 28.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.104 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -94.17 -48.76 6.06 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.025 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 63.54 -84.35 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.207 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.438 ' OD2' ' HB3' ' A' ' 7' ' ' ALA . 20.0 p-10 -86.33 9.62 17.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.151 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 55.09 29.38 12.39 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.237 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.438 ' HB3' ' OD2' ' A' ' 5' ' ' ASP . . . -137.27 -31.46 0.81 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.244 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.4 m -112.26 118.55 35.59 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.271 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.6 mp -88.69 142.16 13.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.845 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.408 ' HB3' ' OG1' ' A' ' 14' ' ' THR . 20.5 m -105.37 152.63 39.93 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.395 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.48 ' O ' ' HB2' ' A' ' 12' ' ' ASP . 10.8 Cg_exo -73.38 18.69 0.39 Allowed 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 123.09 2.526 . . . . 0.0 112.958 -179.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.48 ' HB2' ' O ' ' A' ' 11' ' ' PRO . 21.5 m-20 69.65 138.14 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.034 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 78.18 22.41 68.25 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.194 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.497 ' OG1' ' HB3' ' A' ' 26' ' ' CYS . 70.5 p -129.26 175.02 9.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.83 0.348 . . . . 0.0 111.185 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.546 HG22 ' O ' ' A' ' 27' ' ' SER . 9.9 t -128.79 152.95 47.9 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.01 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.7 m -72.7 112.5 8.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.164 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -127.75 136.93 52.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.657 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.2 mt -91.57 150.22 21.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.076 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.1 p -94.05 161.35 30.02 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.791 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -55.73 -13.91 9.38 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.553 2.169 . . . . 0.0 112.511 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -102.93 -22.03 13.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.848 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 113.29 28.64 3.24 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.633 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 48.5 t -96.96 140.02 18.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.803 0.335 . . . . 0.0 110.947 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 67.3 m95 -93.08 103.42 15.72 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.261 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 55.3 p90 -119.66 168.32 11.16 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.318 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.497 ' HB3' ' OG1' ' A' ' 14' ' ' THR . 15.6 m -107.85 138.13 44.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.927 0.394 . . . . 0.0 111.441 -179.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.546 ' O ' HG22 ' A' ' 15' ' ' THR . 4.8 m -125.73 118.72 24.29 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.697 179.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.493 ' HA ' ' HA ' ' A' ' 14' ' ' THR . 19.9 Cg_exo -65.49 135.3 41.88 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.577 2.184 . . . . 0.0 112.321 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 28.1 p90 . . . . . 0 C--N 1.331 -0.229 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.049 179.921 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 13.6 m . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.796 0.331 . . . . 0.0 111.105 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 12.2 mm -78.33 137.2 22.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.239 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . 0.412 ' CE1' HG12 ' A' ' 9' ' ' ILE . 9.8 m-70 -120.83 -47.46 2.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.847 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 60.94 -87.1 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.38 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.66 -0.0 19.17 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.004 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 59.71 23.14 11.97 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.005 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -120.55 -45.12 2.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.932 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.3 t -104.31 152.47 22.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.933 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.412 HG12 ' CE1' ' A' ' 3' ' ' HIS . 17.9 mt -111.52 136.4 47.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.808 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 16.9 m -137.24 162.13 57.1 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.006 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.405 ' HG2' ' OG1' ' A' ' 14' ' ' THR . 36.8 Cg_endo -66.38 147.18 82.5 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.128 1.886 . . . . 0.0 111.934 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -64.07 -7.72 9.62 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.411 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -104.62 27.51 18.74 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.839 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.405 ' OG1' ' HG2' ' A' ' 11' ' ' PRO . 36.7 p -142.78 173.94 11.1 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.896 0.379 . . . . 0.0 111.258 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 10.0 t -126.33 160.11 31.3 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.025 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -74.04 111.53 9.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.715 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -116.68 136.19 53.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.03 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.557 HD22 ' HA2' ' A' ' 22' ' ' GLY . 5.8 mt -98.37 125.3 43.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.935 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.698 ' HB3' ' HB ' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -80.93 163.96 53.12 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.741 179.995 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.465 ' HG2' ' CE1' ' A' ' 21' ' ' TYR . 9.3 Cg_endo -54.12 -12.38 3.62 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.787 2.325 . . . . 0.0 112.692 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.465 ' CE1' ' HG2' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -116.78 32.47 6.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.927 -179.594 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.557 ' HA2' HD22 ' A' ' 18' ' ' LEU . . . 54.53 55.3 27.76 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.568 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.698 ' HB ' ' HB3' ' A' ' 19' ' ' SER . 40.7 t -116.02 123.84 71.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.824 0.345 . . . . 0.0 111.345 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 97.0 m95 -85.41 93.18 8.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.76 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -113.66 162.23 16.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.048 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -85.28 119.49 25.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.11 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.433 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 4.8 t -111.19 116.19 51.59 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.904 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 27' ' ' SER . 7.4 Cg_exo -73.08 128.32 12.95 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.833 2.355 . . . . 0.0 112.275 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 1.9 p90 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.028 179.953 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 13.4 m . . . . . 0 N--CA 1.485 1.31 0 CA-C-O 120.765 0.317 . . . . 0.0 111.155 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.778 ' HB ' ' HB2' ' A' ' 10' ' ' CYS . 3.8 mp -117.3 113.49 42.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.977 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 25.0 m-70 -102.62 -45.37 5.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.806 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 58.81 -90.13 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.218 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -79.84 4.09 17.63 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.946 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 56.77 27.48 12.84 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.96 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -129.49 -14.14 4.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.104 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.25 123.96 14.15 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.192 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 7.5 mt -86.58 154.99 3.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.992 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.778 ' HB2' ' HB ' ' A' ' 2' ' ' ILE . 22.9 m -144.68 153.14 54.26 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.065 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -63.56 141.39 79.95 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.424 2.083 . . . . 0.0 112.022 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -59.52 104.13 0.25 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.684 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 134.1 0.49 3.82 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.466 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.414 ' O ' HG12 ' A' ' 2' ' ' ILE . 43.6 p -116.97 153.96 31.71 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.822 0.344 . . . . 0.0 111.179 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.424 HG22 ' O ' ' A' ' 27' ' ' SER . 10.1 t -105.31 156.06 18.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.142 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -82.18 113.14 19.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.663 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.1 m -124.65 132.7 53.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.9 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.414 HD23 ' HA ' ' A' ' 18' ' ' LEU . 5.2 mt -89.02 136.47 33.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.022 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -83.15 160.42 60.16 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.513 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -58.07 -11.95 11.45 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.464 2.109 . . . . 0.0 112.529 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.6 24.01 12.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.779 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 62.8 52.64 46.86 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 121.045 -0.598 . . . . 0.0 112.647 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.7 t -124.02 114.76 42.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.726 0.298 . . . . 0.0 110.766 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -72.78 121.09 19.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.064 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 54.9 p90 -137.65 153.68 49.82 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.888 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -90.03 125.64 35.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.093 -179.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.424 ' O ' HG22 ' A' ' 15' ' ' THR . 3.2 t -114.98 118.98 39.83 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.783 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.14 139.73 56.73 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.398 2.065 . . . . 0.0 112.465 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 42.9 p90 -137.12 167.46 21.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.889 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 12.2 t . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.882 179.994 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 1.6 m . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.753 0.311 . . . . 0.0 111.08 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.729 ' HB ' ' HB2' ' A' ' 10' ' ' CYS . 7.5 mm -109.07 121.69 62.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.507 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 10.3 m170 -121.26 119.92 33.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.273 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.2 m -120.29 -18.21 8.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.654 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -146.72 7.85 0.97 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.641 0.258 . . . . 0.0 111.248 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 55.91 21.46 4.91 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.214 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -124.03 -51.76 1.78 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.961 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.2 m -105.45 92.44 4.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.965 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 22.4 mt -67.92 137.06 25.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.22 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.729 ' HB2' ' HB ' ' A' ' 2' ' ' ILE . 9.5 m -117.04 159.52 40.74 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.775 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -79.05 145.7 19.68 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.34 2.027 . . . . 0.0 111.992 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -61.53 109.59 1.22 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.872 0.368 . . . . 0.0 110.844 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 130.12 14.64 1.99 Allowed Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.635 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.1 p -139.11 154.07 48.09 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.749 0.309 . . . . 0.0 111.156 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.1 t -104.27 153.06 21.46 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.177 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.2 m -73.61 114.01 11.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.055 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.432 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 0.4 OUTLIER -120.87 129.99 53.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.596 179.773 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.4 mt -94.46 140.01 30.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.888 0.375 . . . . 0.0 111.181 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.562 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 0.1 OUTLIER -86.77 162.03 45.82 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.532 179.805 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.31 -8.06 6.12 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.458 2.105 . . . . 0.0 112.714 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -118.05 23.68 11.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.824 0.345 . . . . 0.0 111.094 -179.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.28 46.77 85.66 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.673 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.562 ' HB ' ' HB2' ' A' ' 19' ' ' SER . 60.6 t -113.82 117.73 56.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.805 0.336 . . . . 0.0 110.74 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 87.5 m95 -77.78 117.06 18.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.35 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.432 ' CE2' ' HB3' ' A' ' 17' ' ' SER . 53.8 p90 -137.98 147.22 44.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.501 179.241 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -85.31 122.81 30.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.096 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 24.9 t -116.03 125.5 28.55 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.033 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -71.93 152.0 57.13 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.482 2.121 . . . . 0.0 112.324 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -108.1 -30.43 8.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.856 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 11.7 t . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.26 -0.876 . . . . 0.0 110.933 179.92 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.408 ' HB ' ' H ' ' A' ' 2' ' ' ILE . 1.8 m . . . . . 0 N--CA 1.486 1.329 0 CA-C-O 120.751 0.31 . . . . 0.0 111.119 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.658 HD11 ' HA ' ' A' ' 12' ' ' ASP . 6.1 mm -121.09 135.65 60.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.1 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 70.8 m-70 -138.42 87.48 2.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.794 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 12.0 m -79.15 -53.37 7.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.985 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -114.68 11.35 16.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.116 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 56.01 23.57 6.88 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.335 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -115.79 -56.6 2.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.077 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 87.4 m -105.68 100.32 9.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.023 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.407 ' H ' HG13 ' A' ' 9' ' ' ILE . 6.3 mt -68.83 128.63 32.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.728 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.2 m -119.59 150.36 49.9 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.207 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -59.18 147.8 88.89 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.631 2.221 . . . . 0.0 112.358 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.658 ' HA ' HD11 ' A' ' 2' ' ' ILE . 7.2 p-10 -58.66 -25.35 62.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.406 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -88.49 21.28 26.37 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.694 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.1 p -146.14 177.6 8.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.843 0.354 . . . . 0.0 111.194 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.443 HG22 ' O ' ' A' ' 27' ' ' SER . 6.7 t -132.57 159.96 37.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.02 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -84.16 105.33 14.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.1 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -118.35 139.65 51.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.491 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.424 HD23 ' HA ' ' A' ' 18' ' ' LEU . 8.4 mt -92.85 143.96 25.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.03 0.443 . . . . 0.0 111.328 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.7 164.04 18.34 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.403 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_exo -58.36 -4.8 1.88 Allowed 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.491 2.127 . . . . 0.0 112.812 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -117.61 21.53 12.92 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.799 0.333 . . . . 0.0 110.91 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 62.91 44.36 97.54 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.534 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 54.2 t -113.0 132.55 61.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.755 0.312 . . . . 0.0 110.866 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 82.7 m95 -91.06 104.84 17.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.219 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 55.1 p90 -118.3 152.74 35.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.557 179.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.433 ' HA ' ' O ' ' A' ' 15' ' ' THR . 1.8 m -91.86 117.06 29.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.026 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.443 ' O ' HG22 ' A' ' 15' ' ' THR . 0.1 OUTLIER -105.47 132.58 20.76 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.726 179.911 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -74.14 140.42 28.02 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.339 2.026 . . . . 0.0 112.515 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -139.39 178.28 7.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.905 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 23.0 t . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.188 -0.911 . . . . 0.0 110.851 179.949 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 26.9 m . . . . . 0 N--CA 1.485 1.315 0 CA-C-O 120.789 0.328 . . . . 0.0 111.062 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.571 ' HB ' ' HB2' ' A' ' 10' ' ' CYS . 12.6 mm -121.48 119.75 59.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.245 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -126.62 85.17 2.35 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.72 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.2 m -72.26 -58.84 3.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.997 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -115.82 32.55 6.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.063 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 58.4 15.76 3.69 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.205 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -136.58 155.62 49.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.74 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 72.3 m 53.37 86.75 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.91 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 18.8 mt -71.21 130.6 35.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.092 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.571 ' HB2' ' HB ' ' A' ' 2' ' ' ILE . 13.0 m -112.29 155.08 44.13 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.809 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -64.41 139.97 67.59 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.516 2.144 . . . . 0.0 112.162 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -59.65 104.27 0.27 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.863 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 138.65 -12.12 3.44 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.473 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.445 ' OG1' ' HB3' ' A' ' 26' ' ' CYS . 47.5 p -108.04 161.52 14.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.763 0.316 . . . . 0.0 111.121 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.469 HG22 ' O ' ' A' ' 27' ' ' SER . 6.4 t -111.28 144.87 39.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.089 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -76.33 114.25 14.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.874 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.7 t -122.1 139.96 53.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.849 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.441 ' HA ' HD23 ' A' ' 18' ' ' LEU . 6.5 mt -95.06 125.73 39.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.899 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.25 159.91 81.2 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.774 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -54.04 -12.04 3.19 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.792 2.328 . . . . 0.0 112.851 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -105.19 -27.2 11.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.969 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 117.27 52.95 0.32 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.516 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 23.3 t -124.7 129.57 73.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.766 0.317 . . . . 0.0 111.042 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 92.7 m95 -82.78 99.24 9.56 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.04 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -116.36 151.7 35.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.727 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.445 ' HB3' ' OG1' ' A' ' 14' ' ' THR . 0.2 OUTLIER -89.18 127.36 35.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.247 -179.638 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.469 ' O ' HG22 ' A' ' 15' ' ' THR . 0.4 OUTLIER -118.49 114.21 36.31 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.717 179.778 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -66.55 130.64 24.08 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.411 2.074 . . . . 0.0 112.194 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 12.7 p90 -113.11 178.15 4.38 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.849 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.177 -0.916 . . . . 0.0 110.874 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 17.1 m . . . . . 0 N--CA 1.485 1.308 0 CA-C-O 120.775 0.322 . . . . 0.0 111.175 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.586 HD11 ' HA ' ' A' ' 12' ' ' ASP . 3.3 mm -101.3 145.22 11.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.114 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 26.1 m-70 -133.9 -33.6 1.04 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.915 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.446 ' HB2' ' H ' ' A' ' 5' ' ' ASP . 0.4 OUTLIER 55.51 -94.05 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.164 179.894 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.446 ' H ' ' HB2' ' A' ' 4' ' ' CYS . 0.9 OUTLIER -94.37 30.71 1.89 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.8 0.333 . . . . 0.0 110.666 179.881 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 60.91 14.49 5.28 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.068 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -134.85 153.31 52.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.818 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 90.2 m 55.64 87.29 0.05 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.864 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 8.0 mt -69.28 146.88 12.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.151 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 7.0 m -138.74 157.58 71.64 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.832 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -62.97 145.74 94.5 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.485 2.123 . . . . 0.0 112.085 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.586 ' HA ' HD11 ' A' ' 2' ' ' ILE . 3.3 p-10 -60.76 -21.3 62.88 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.11 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -85.3 14.15 51.66 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.663 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.449 ' OG1' ' HB3' ' A' ' 26' ' ' CYS . 66.5 p -140.47 171.08 14.63 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.819 0.343 . . . . 0.0 111.187 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.48 HG22 ' O ' ' A' ' 27' ' ' SER . 8.9 t -126.71 162.53 25.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.109 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -74.98 120.76 20.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.969 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -128.19 131.98 48.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.586 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.438 HD23 ' HA ' ' A' ' 18' ' ' LEU . 6.1 mt -91.84 124.98 36.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.886 0.374 . . . . 0.0 111.135 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.49 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 0.1 OUTLIER -78.95 162.38 64.98 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.522 179.702 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -56.12 -11.41 5.77 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.487 2.124 . . . . 0.0 112.616 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -113.76 26.2 10.56 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.072 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 59.01 59.07 11.44 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.587 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.49 ' HB ' ' HB2' ' A' ' 19' ' ' SER . 41.0 t -126.64 120.52 56.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.824 0.345 . . . . 0.0 111.282 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 94.7 m95 -81.25 99.62 8.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.902 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 56.0 p90 -117.82 161.75 19.22 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.926 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.449 ' HB3' ' OG1' ' A' ' 14' ' ' THR . 0.0 OUTLIER -87.07 129.0 35.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.092 -179.768 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.48 ' O ' HG22 ' A' ' 15' ' ' THR . 0.1 OUTLIER -130.11 117.15 17.97 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.895 -179.991 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -61.74 144.77 97.44 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.494 2.129 . . . . 0.0 112.215 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -113.0 157.81 21.05 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.869 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.363 -0.827 . . . . 0.0 110.985 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 2.9 m . . . . . 0 N--CA 1.485 1.316 0 CA-C-O 120.832 0.348 . . . . 0.0 111.148 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.513 HD11 ' HA ' ' A' ' 12' ' ' ASP . 3.0 mm -103.48 159.08 4.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.907 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 17.2 m-70 -137.25 -64.21 0.57 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.913 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 15.2 m 60.93 -86.4 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.194 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -74.73 -4.93 40.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.918 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 56.89 22.83 7.5 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.41 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -134.5 -21.46 1.76 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.024 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 42.8 m -130.46 94.26 3.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.972 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 10.8 mt -64.14 132.58 30.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.895 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.446 ' O ' HG12 ' A' ' 2' ' ' ILE . 6.4 m -120.27 153.33 55.72 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.164 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -56.59 142.88 90.2 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.603 2.202 . . . . 0.0 112.335 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.513 ' HA ' HD11 ' A' ' 2' ' ' ILE . 21.2 t0 -57.58 -24.28 55.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.379 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -92.69 21.47 38.74 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.884 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 82.2 p -141.28 173.77 11.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.902 0.382 . . . . 0.0 111.245 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.5 t -130.66 155.42 46.61 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.92 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -73.47 120.39 19.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.93 0.395 . . . . 0.0 110.986 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.6 t -132.18 135.92 46.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.52 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.1 mt -99.99 132.59 45.26 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.922 0.391 . . . . 0.0 111.073 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 6.1 p -77.61 163.1 65.75 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.794 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.45 -6.43 4.17 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.592 2.195 . . . . 0.0 112.68 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -117.1 20.57 13.7 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.813 0.339 . . . . 0.0 111.096 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.52 47.58 76.69 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.903 -0.665 . . . . 0.0 113.009 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 51.8 t -117.6 117.15 54.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.765 0.317 . . . . 0.0 110.755 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -71.32 124.49 24.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.322 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 46.8 p90 -147.65 147.12 29.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.364 179.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -91.02 124.34 35.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.932 0.396 . . . . 0.0 111.275 -179.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 11.0 t -108.39 127.72 26.98 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.423 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -76.08 126.62 9.4 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.316 2.011 . . . . 0.0 112.445 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -101.07 -15.84 17.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.816 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 9.6 p . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.251 -0.881 . . . . 0.0 110.959 -179.909 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 6.1 m . . . . . 0 N--CA 1.485 1.315 0 CA-C-O 120.811 0.339 . . . . 0.0 111.024 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.68 ' HB ' ' HB2' ' A' ' 10' ' ' CYS . 4.7 mm -120.15 104.1 15.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.043 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 -95.49 74.96 3.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.919 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.421 ' HB2' ' HB ' ' A' ' 8' ' ' THR . 4.1 m -62.73 113.06 2.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.85 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 59.98 18.19 7.35 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.088 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 55.69 26.26 9.14 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.381 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -137.95 -2.07 1.93 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.253 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.421 ' HB ' ' HB2' ' A' ' 4' ' ' CYS . 21.7 m -143.28 108.3 4.95 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.285 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 5.8 mt -84.44 143.32 11.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.869 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.68 ' HB2' ' HB ' ' A' ' 2' ' ' ILE . 12.3 m -145.8 154.62 51.8 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.203 -179.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -57.86 143.5 95.63 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.536 2.158 . . . . 0.0 112.21 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -54.83 -31.77 59.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.282 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -85.15 23.33 8.21 Favored Glycine 0 CA--C 1.518 0.276 0 C-N-CA 120.892 -0.67 . . . . 0.0 113.253 -179.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 81.6 p -142.61 165.07 28.4 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.835 0.35 . . . . 0.0 111.259 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.448 HG22 ' O ' ' A' ' 27' ' ' SER . 8.2 t -124.69 164.1 20.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.018 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 3.6 m -80.47 118.76 22.36 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.259 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.9 m -125.49 140.66 52.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.365 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.439 HD23 ' HA ' ' A' ' 18' ' ' LEU . 7.0 mt -94.28 131.92 39.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.011 0.434 . . . . 0.0 111.467 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.63 163.83 34.26 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.411 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -56.62 -8.36 2.84 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.549 2.166 . . . . 0.0 112.665 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -115.82 25.84 10.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.024 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 58.91 35.43 82.99 Favored Glycine 0 C--N 1.33 0.201 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.684 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 59.3 t -105.45 124.9 60.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.872 0.368 . . . . 0.0 111.039 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 80.9 m95 -82.29 112.33 19.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.205 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 49.3 p90 -125.18 154.0 42.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.682 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -86.44 129.12 34.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.923 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.448 ' O ' HG22 ' A' ' 15' ' ' THR . 28.1 t -130.96 125.33 21.17 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.03 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 27' ' ' SER . 16.3 Cg_exo -68.35 149.35 75.25 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.753 2.302 . . . . 0.0 112.204 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -104.99 -19.37 13.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.93 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 29.0 t . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.213 -0.899 . . . . 0.0 111.107 -179.959 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 3.9 m . . . . . 0 N--CA 1.485 1.314 0 CA-C-O 120.835 0.35 . . . . 0.0 111.172 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.819 ' HB ' ' HB2' ' A' ' 10' ' ' CYS . 5.2 mm -92.27 129.27 43.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.245 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 16.8 m-70 -121.61 -44.13 2.35 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.088 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.566 ' SG ' HG22 ' A' ' 2' ' ' ILE . 0.7 OUTLIER 58.8 -90.84 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.5 179.875 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.48 ' H ' ' HB2' ' A' ' 4' ' ' CYS . 0.8 OUTLIER -79.61 2.51 22.15 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.088 -179.649 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 58.23 16.76 4.17 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.364 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -100.98 -36.24 9.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.85 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 14.8 t -125.33 159.67 31.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.915 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 44.0 mt -111.1 142.59 23.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.93 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.819 ' HB2' ' HB ' ' A' ' 2' ' ' ILE . 56.4 m -134.43 157.22 77.89 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.905 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -76.38 141.33 22.69 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.308 2.006 . . . . 0.0 112.167 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -55.43 99.96 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.116 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 140.59 -4.79 2.53 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.471 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.421 ' O ' HG13 ' A' ' 2' ' ' ILE . 12.2 p -113.12 151.31 30.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.726 0.298 . . . . 0.0 110.867 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.2 t -105.21 152.73 22.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.281 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -76.21 112.49 12.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.646 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -120.69 141.74 50.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.078 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.551 HD22 ' HA2' ' A' ' 22' ' ' GLY . 6.6 mt -97.65 125.79 42.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.799 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.44 ' HB3' ' HB ' ' A' ' 23' ' ' VAL . 0.3 OUTLIER -77.6 164.06 60.11 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.785 -179.89 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.466 ' HG2' ' CZ ' ' A' ' 21' ' ' TYR . 9.5 Cg_endo -54.6 -12.08 3.97 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 122.742 2.295 . . . . 0.0 112.691 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.466 ' CZ ' ' HG2' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -117.57 30.11 7.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.035 -179.518 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.551 ' HA2' HD22 ' A' ' 18' ' ' LEU . . . 56.8 48.81 75.25 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.568 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.44 ' HB ' ' HB3' ' A' ' 19' ' ' SER . 16.2 t -113.46 117.15 54.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.795 0.331 . . . . 0.0 111.066 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -76.07 105.06 6.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.209 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -123.47 156.48 35.49 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.834 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 1.6 m -87.95 108.28 19.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.224 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -94.55 117.38 66.99 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.632 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.35 127.33 13.22 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.467 2.111 . . . . 0.0 112.484 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -119.21 -21.63 7.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.006 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.877 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 16.0 m . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.822 0.344 . . . . 0.0 111.145 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 13.3 mm -84.35 116.74 28.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.104 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -94.17 -48.76 6.06 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.025 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 63.54 -84.35 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.207 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.438 ' OD2' ' HB3' ' A' ' 7' ' ' ALA . 20.0 p-10 -86.33 9.62 17.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.151 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 55.09 29.38 12.39 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.237 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.438 ' HB3' ' OD2' ' A' ' 5' ' ' ASP . . . -137.27 -31.46 0.81 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.244 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.4 m -112.26 118.55 35.59 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.271 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.6 mp -88.69 142.16 13.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.845 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.408 ' HB3' ' OG1' ' A' ' 14' ' ' THR . 20.5 m -105.37 152.63 39.93 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.395 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.48 ' O ' ' HB2' ' A' ' 12' ' ' ASP . 10.8 Cg_exo -73.38 18.69 0.39 Allowed 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 123.09 2.526 . . . . 0.0 112.958 -179.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.48 ' HB2' ' O ' ' A' ' 11' ' ' PRO . 21.5 m-20 69.65 138.14 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.034 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 78.18 22.41 68.25 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.194 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.497 ' OG1' ' HB3' ' A' ' 26' ' ' CYS . 70.5 p -129.26 175.02 9.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.83 0.348 . . . . 0.0 111.185 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.546 HG22 ' O ' ' A' ' 27' ' ' SER . 9.9 t -128.79 152.95 47.9 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.01 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.7 m -72.7 112.5 8.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.164 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -127.75 136.93 52.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.657 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.2 mt -91.57 150.22 21.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.076 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.1 p -94.05 161.35 30.02 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.791 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -55.73 -13.91 9.38 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.553 2.169 . . . . 0.0 112.511 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -102.93 -22.03 13.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.848 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 113.29 28.64 3.24 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.633 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 48.5 t -96.96 140.02 18.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.803 0.335 . . . . 0.0 110.947 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 67.3 m95 -93.08 103.42 15.72 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.261 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 55.3 p90 -119.66 168.32 11.16 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.318 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.497 ' HB3' ' OG1' ' A' ' 14' ' ' THR . 15.6 m -107.85 138.13 44.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.927 0.394 . . . . 0.0 111.441 -179.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.546 ' O ' HG22 ' A' ' 15' ' ' THR . 4.8 m -125.73 118.72 24.29 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.697 179.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.493 ' HA ' ' HA ' ' A' ' 14' ' ' THR . 19.9 Cg_exo -65.49 135.3 41.88 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.577 2.184 . . . . 0.0 112.321 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 28.1 p90 -118.82 167.72 11.44 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.049 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.179 -0.915 . . . . 0.0 111.073 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 13.6 m . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.796 0.331 . . . . 0.0 111.105 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 12.2 mm -78.33 137.2 22.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.239 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.412 ' CE1' HG12 ' A' ' 9' ' ' ILE . 9.8 m-70 -120.83 -47.46 2.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.847 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 60.94 -87.1 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.38 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.66 -0.0 19.17 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.004 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 59.71 23.14 11.97 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.005 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -120.55 -45.12 2.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.932 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.3 t -104.31 152.47 22.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.933 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.412 HG12 ' CE1' ' A' ' 3' ' ' HIS . 17.9 mt -111.52 136.4 47.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.808 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 16.9 m -137.24 162.13 57.1 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.006 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.405 ' HG2' ' OG1' ' A' ' 14' ' ' THR . 36.8 Cg_endo -66.38 147.18 82.5 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.128 1.886 . . . . 0.0 111.934 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -64.07 -7.72 9.62 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.411 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -104.62 27.51 18.74 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.839 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.405 ' OG1' ' HG2' ' A' ' 11' ' ' PRO . 36.7 p -142.78 173.94 11.1 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.896 0.379 . . . . 0.0 111.258 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 10.0 t -126.33 160.11 31.3 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.025 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -74.04 111.53 9.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.715 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -116.68 136.19 53.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.03 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.557 HD22 ' HA2' ' A' ' 22' ' ' GLY . 5.8 mt -98.37 125.3 43.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.935 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.698 ' HB3' ' HB ' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -80.93 163.96 53.12 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.741 179.995 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.465 ' HG2' ' CE1' ' A' ' 21' ' ' TYR . 9.3 Cg_endo -54.12 -12.38 3.62 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.787 2.325 . . . . 0.0 112.692 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.465 ' CE1' ' HG2' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -116.78 32.47 6.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.927 -179.594 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.557 ' HA2' HD22 ' A' ' 18' ' ' LEU . . . 54.53 55.3 27.76 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.568 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.698 ' HB ' ' HB3' ' A' ' 19' ' ' SER . 40.7 t -116.02 123.84 71.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.824 0.345 . . . . 0.0 111.345 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 97.0 m95 -85.41 93.18 8.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.76 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -113.66 162.23 16.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.048 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -85.28 119.49 25.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.11 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.433 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 4.8 t -111.19 116.19 51.59 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.904 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 27' ' ' SER . 7.4 Cg_exo -73.08 128.32 12.95 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.833 2.355 . . . . 0.0 112.275 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -101.31 -0.28 35.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.028 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.5 m . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.928 179.993 . . . . . . . . 0 0 . 1 stop_ save_